Page last updated: 2024-08-23

ursodeoxycholic acid and Liver Dysfunction

ursodeoxycholic acid has been researched along with Liver Dysfunction in 222 studies

Research

Studies (222)

TimeframeStudies, this research(%)All Research%
pre-199018 (8.11)18.7374
1990's75 (33.78)18.2507
2000's57 (25.68)29.6817
2010's57 (25.68)24.3611
2020's15 (6.76)2.80

Authors

AuthorsStudies
Ma, T; Mo, W; Pan, Z; Ren, H; Wang, F; Xie, M; Xie, Y; Zhou, C1
Harpavat, S; Hernandez, J; Hicks, MJ; Killelea, P; Sakhuja, S1
Bloks, VW; de Boer, JF; de Vries, HD; Hovingh, MV; Koehorst, M; Kuipers, F; Li, R; Mulder, NL; Palmiotti, A; van Zutphen, T1
John, BV; Mansour, N; Shaker, M1
Racila, A; Stepanova, M; Younossi, I; Younossi, ZM1
Cui, X; Li, X; Li, Y; Lin, Y; Zhu, N1
Guan, L; Li, X; Li, Y; Lin, X; Wang, N; Zhang, X1
Liu, T; Wang, JS1
Bedossa, P; Bowlus, CL; Drenth, JPH; Forman, LM; Iloeje, U; Jin, Y; Kremer, AE; Liberman, A; MacConell, L; Parés, A; Pencek, R; Pockros, PJ; Ryder, SD; Terracciano, L1
Combalia, A; Dubreuil, M; Guañabens, N; Jurado, S; Monegal, A; Parés, A; Peris, P; Ruiz-Gaspà, S1
Banales, JM; Briz, O; Bujanda, L; Caballero-Camino, FJ; Cossío, FP; Esteller, M; Gradilone, SA; Herraez, E; Izquierdo-Sanchez, L; Jin, S; Lee-Law, PY; Marin, JJG; Munoz-Garrido, P; Peixoto, E; Perugorria, MJ; Richard, S; Rivilla, I; Rodrigues, PM; Santos-Laso, A1
Staufer, K1
Anderson, KE; Center, SA; Choi, AE; Kunz, BC; Randolph, JF; Walker, JD1
Aldigeri, R; Battaglia, L; Gelsi, E; Quintavalla, F; Ramoni, R1
Barbier, O; Cieślak, A; Gobeil, S; Perreault, M; Thérien, A; Trottier, J; Verreault, M; Vohl, MC1
Beuers, U; Hohenester, S1
Bertolini, A; Bodewes, FAJA; Jonker, JW; van de Peppel, IP; Verkade, HJ1
Ashby, D; Cheng, K; Smyth, RL3
Kim, HS; Kim, JS; Lee, DK; Lee, JH; Lim, JH1
Vollmer, H1
Al Qatarneh, S; Lindblad, D; Michel, HK; Ozolek, J; Venkat, V; Weiner, DJ1
Boëlle, PY; Clement, A; Corvol, H; Debray, D; Guillot, L1
Blomenkamp, KS; Fickert, P; Tang, Y; Teckman, JH; Trauner, M1
Cho, JY; Chung, JY; Jang, IJ; Ji, SC; Kim, DJ; Kim, YK; Lee, S; Yang, J; Yoon, S; Yu, KS1
Poupon, R1
Lenzi, M; Muratori, L; Muratori, P1
Amelung, L; Arends, JE; de Bruijne, J; Leoni, MC; Lieveld, FI; van den Brink, J; van Erpecum, CP; van Erpecum, KJ1
Bancel, B; Brunel, T; Goubault, P; Mabrut, JY; Mohkam, K; Rode, A1
Heller, T; Kleiner, DE; Koh, C; Sakiani, S1
Herrera, JL; Kumar, M1
Arab, JP; Arrese, M; Cabrera, D1
Hagymási, K; Tulassay, Z1
Fan, D; Han, Y; Han, Z; Huang, X; Li, T; Li, Z; Shi, Y; Wang, J; Wang, L; Wang, M; Wang, R; Wang, X; Zhou, X1
Grigor'eva, GA; Meshalkina, NIu1
Fisher, SE; Rabinowitz, SS; Schwarz, SM; Vo, HD; Xu, J1
Drozdova, LIu; Iakhontov, DA; Kutishenko, NP; Lerman, OV; Martsevish, SIu; Nevzorova, VA; Reznik, II; Shavkuta, GV1
Radchenko, VG; Seliverstov, PV; Sitkin, SI1
Banales, JM; Beuers, U; Bujanda, L; Concepcion, AR; Drenth, JP; Erice, O; Hijona, E; Jimenez-Agüero, R; LaRusso, NF; Marin, JJ; Marzioni, M; Masyuk, TV; Monte, MJ; Munoz-Garrido, P; Perugorria, MJ; Portu, A; Prieto, J; Romero, MR; Sáez, E; Santos-Laso, Á; Sarvide, S; Úriz, M; Urribarri, AD1
Claudel, T; Fickert, P; Fuchs, C; Halilbasic, E; Hofer, H; Kazemi-Shirazi, L; Kienbacher, C; Krones, E; Moustafa, T; Munda, P; Paumgartner, G; Pollheimer, M; Steinacher, D; Trauner, M; Traussnigg, S1
Hasegawa, E; Hayami, N; Hiramatsu, R; Hoshino, J; Iijima, T; Imafuku, A; Kawada, M; Mise, K; Sawa, N; Sumida, K; Suwabe, T; Takaichi, K; Ubara, Y1
Higashi, T; Kariyama, K; Kishida, M; Nishimura, M; Nouso, K; Wada, N; Wakuta, A1
Cecchi, N; Garzi, A; Mandato, C; Orso, G; Vajro, P; Veropalumbo, C1
Drzymała-Czyż, S; Jończyk-Potoczna, K; Lisowska, A; Stajgis, M; Walkowiak, J1
Chang, JW; Chen, JS; Hsu, HC; Huang, WK; Kuo, CF; Lin, YC; Liu, JR; See, LC; Yang, TS; Yu, KH1
Banales, JM; Beuers, U; Brunenberg, EJ; Bujanda, L; D'Agnolo, HM; Drenth, JP; Kievit, W; Neijenhuis, MK; Riaño, I; Takkenberg, RB1
Alicandro, G; Biffi, A; Colombo, C; Corti, F; Crosignani, A; Motta, V; Setchell, KDR; Zhang, W1
Narkewicz, MR1
Alawad, AS; Levy, C1
Ayadi, S; Bougassas, W; Cheikh, M; Ennaifer, R; Hadj, NB; Nejma, HB; Romdhane, H1
Halilbasic, E; Steinacher, D; Trauner, M1
Azzaroli, F; Colecchia, A; Di Biase, AR; Festi, D; Lodato, F; Mazzella, G; Montagnani, M; Roda, A; Roda, E; Simoni, P1
Moreno Villares, JM1
Blum, HE; Panther, E1
Bernard, O; Broué, P; Dabadie, A; Ducot, B; Jacquemin, E; Lachaux, A; Lykavieris, P; Sarles, J1
González-Gallego, J; Mauriz, JL; Tuñón, MJ1
Adam, R; Reinshagen, K; Trunk, M; Wessel, LM1
Cooper, J; Webster, CR1
Akoglu, B; Faust, D; Milovic, V; Ristic, G1
Decock, S; Hirschfield, GM; McGee, P1
Houwen, RH; Klomp, LW; Stapelbroek, JM; van Erpecum, KJ1
Boggia, B; Buonpensiero, P; De Gregorio, F; Di Pasqua, A; Ferri, P; Raia, V; Sepe, A; Siano, M1
Brodlie, S; Carroll, J; Cowles, RA; Harren, PA; Jan, DM; Lobritto, SJ; Martinez, M; Ventura, KA1
Gunji, N; Irisawa, A; Ishihata, R; Kaise, S; Ohira, H; Saito, A; Takano, M; Utsumi, Y1
Alaggio, R; D'Antiga, L; Giordano, G; Guido, M; Riello, L; Zancan, L1
Aygören, R; Günşar, C; Mir, E; Sencan, A; Türköz, E; Var, A; Vatansever, S; Yilmaz, O1
Baussan, C; Davit-Spraul, A; Gonzales, E; Jacquemin, E1
Amaral, JD; Rodrigues, CM; Steer, CJ; Xavier, JM1
Il'chenko, AA2
Dockter, G; Herrmann, U; Lammert, F1
Beuers, U; Denk, GU; Ferdinandusse, S; Fickert, P; Fuchsbichler, A; Hofmann, AF; Invernizzi, P; Kulik, W; Maitz, S; Rust, C; Trauner, M; Wimmer, R1
Giljaca, V; Gluud, C; Poropat, G; Stimac, D1
Golovanova, EV; Noskova, KK; Petrakov, AV1
Bozdag, S; Dilmen, U; Erdeve, O; Gokmen, T; Oguz, SS; Uras, N1
Baughman, RP; Cremers, JP; Drent, M; Koek, GH; Wijnen, PA1
Bakker, GJ; Beuers, U; Haan, YC; Maillette de Buy Wenniger, LJ1
Poupon, R; Serfaty, L1
Duggan, C; Raphael, BP1
Beuers, U; Paumgartner, G2
Eriksson, B; Hägglund, H; Juvonen, E; Parkkali, T; Remberger, M; Remes, K; Ringdén, O; Ruutu, T; Volin, L1
Cortes, J; Estey, E; Garcia-Manero, G; Giles, F; Kantarjian, H; Thomas, D1
Adler, G; Reinshagen, M1
Knottenbelt, CM; McGrotty, YL; Ramsey, IK1
Burroughs, AK; Mancuso, A; Mela, M1
Matsuzaki, Y; Nishikawa, K1
Beuers, U; Dilger, K; Hempfling, W1
Iida, N; Koike, M; Ogawa, K; Oshimi, K; Sekigawa, I1
Bayer, EM; Kanzler, S; Lohse, AW; Schramm, C1
Hoskins, AC; Lewindon, PJ; O'Connell, NC; Pereira, TN; Ramm, GA; Setchell, KD; Shepherd, RW; Smith, JL1
Blum, HE1
Bueverov, AO1
Alenezi, B; Alpert, L; Lamoureux, E; Szilagyi, A1
Gondo, H; Harada, M; Hashiguchi, M; Higuchi, M; Imamura, R; Kato, K; Kuroiwa, M; Nagafuji, K; Ogata, H; Okamura, T; Oku, E; Ono, N; Otsubo, K; Sata, M; Seki, R; Shibuya, T; Taniguchi, S; Yakushiji, K; Yoshimoto, K1
Akan, H; Arat, M; Erden, E; Idilman, R; Karayalçin, S; Soydan, EA; Soykan, I1
Fickert, P; Geier, A; Trauner, M1
Brok, J; Gluud, C; Gong, Y; Koretz, RL1
Adams, PC; Assy, N; Ghent, CN; Minuk, GY; Myers, P; Simon, V; Wall, W1
Il'chenko, LIu; Mikheeva, OM1
Allard, JP; Raman, M1
Fukunari, A; Imada, T; Ishizaki, K; Iwaki, T; Kinoshita, S; Tanaka, H; Tsurufuji, M1
Chiba, K; Fukunari, A; Imada, T; Ishizaki, K; Iwaki, T; Kinoshita, S; Koyama, M; Maeda, Y; Sakata, K; Tanaka, H; Tsurufuji, M1
Duarte-Rojo, A; Martínez-Benítez, B; Sánchez-Osorio, M; Torre, A; Uribe, M1
Avsar, E; Aygun, C; Celikel, C; Eren, F; Haklar, G; Hulagu, S; Senturk, O; Tahan, V; Tozun, N; Unluguzel, G; Uraz, S; Yuksel, M1
Gabe, SM; Lloyd, DA1
Bailey, M; Clark, D; Desmond, CP; Roberts, SK; Wilson, J1
Alexander, GJ; Allison, ME; Bilton, D; Haworth, CS; Lomas, DJ; McKeon, D; Nash, KL1
Shan, RB; Zhu, MZ1
Chernyshev, AL; Maksimov, VA; Shelemov, EE1
Barois, A; Bataille, J; Do Ngoc Thanh, C; Estournet-Mathiaud, B; Ioos, C1
Hofmann, AF; van Berge-Henegouwen, GP1
Miescher, G; Paumgartner, G; Preisig, R1
Imawari, M; Matsuzaki, Y; Mitamura, K; Osuga, T; Shoda, J1
Buffet, C; Chaput, JC; Etienne, JP; Franco, D; Houssin, D; Labayle, D1
Bull, HJ; Coltart, DJ; Gilmore, IT; Marigold, JH; Thompson, RP1
Inaguma, H1
Baker, D; Gochman, N; Javitt, NB; Jones, HM; Miyai, K1
Shinozaki, K1
Fukushima, K; Hino, K; Ohashi, K; Yamamoto, S; Yamashita, S1
Allan, RN; Dew, MJ; Huybregts, AW; van Berge Henegouwen, GP1
Stiehl, A2
Blanc, P; Domergue, J; Fabre, JM; Larrey, D; Michel, H; Navarro, F; Pageaux, GP; Perrigault, PF; Souche, B1
Tanner, MS; Taylor, CJ1
Batta, AK; Chen, T; Kren, BT; Nguyen, LB; Salen, G; Shefer, S; Steer, CJ; Tint, GS1
Cerrè, C; Forti, GC; Gioacchini, AM; Natalini, B; Pellicciari, R; Polimeni, C; Roda, A; Sadeghpour, B; Sapigni, E1
Eriksson, S; Sahlin, S1
Kawasaki, H; Murawaki, Y1
Kimura, A; Makino, I; Nakamura, K1
Angelico, M; Antonelli, M; Bertasi, S; De Santis, A; Diamanti, S; Goffredo, F; Martino, F; Merli, M; Quattrucci, S; Servi, R1
Hofmann, AF2
Lindblad, A; Strandvik, B1
Leuschner, U1
Enomoto, M; Sadamoto, T; Sato, G; Shibata, M; Tuzimoto, S; Ueno, Y; Watanabe, M; Yamagami, T; Yasushi, T1
Michael, S; Simko, V1
Loizeau, E1
Montet, JC; Queneau, PE1
van Berge-Henegouwen, GP; Van de Meeberg, PC; van Erpecum, KJ1
Khandelwal, M; Kowalski, TE; Malet, PF; Rubin, RA1
Luketic, VA; Sanyal, AJ1
Cirillo, NW; Zwas, FR1
van Berge Henegouwen, GP; van de Meeberg, PC; van Erpecum, KJ1
Apostolo, MG; Bettinardi, N; Colombo, C; Crosignani, A; Giunta, A; Marzano, MT1
Hotta, H; Makino, I; Nakamura, K1
Alonso, JR; Badia, MD; el-Mir, MY; Marin, JJ; Monte, MJ; Palomero, F1
Ansari, GG; Cosentino, CM; Das, JB; Levy, MF; Raffensperger, JG1
Carughi, S; Lucentini, L; Sperandeo, G; Sperandeo, M; Varriale, A1
Bowler, IM; Irving, HC; Littlewood, JM; O'Connor, PJ; Robinson, PJ; Southern, KW1
Manns, MP; Schmidt, HH1
Battezzati, PM; Bettinardi, N; Colombo, C; Giunta, A; Podda, M1
Moriwaki, H; Muto, Y; Nishigaki, Y; Ohnishi, H1
Dingemans, KP; Elferink, RP; Groen, AK; Offerhaus, GJ; Ottenhoff, R; Tytgat, GN; Van Den Bergh Weerman, MA; Van Nieuwkerk, CM1
Aoshima, M; Fujita, M; Hasegawa, T; Kato, T; Kimura, A; Makino, I; Nakamura, K; Saito, H; Sato, Y; Tamori, K; Yokohama, S; Yoneda, M1
Crosignani, A; Invernizzi, P; Larghi, A; Podda, M; Rodrigues, CM; Setchell, KD1
Burke, AF; Campbell, GR; FitzGerald, MX; Hegarty, JE; Maguire, OC; O'Brien, SM; Rowlands, BJ1
Aversa, F; Balo', S; Clerici, C; Gentili, G; Martelli, M; Modesto, R; Morelli, A; Morselli-Labate, AM; O'Connell, N; Rusticali, G; Setchell, KD1
Bateson, MC1
Sheptulin, AA1
Benkerrou, M; de Graeff-Meeder, BR; Fischer, A; Haddad, E; Patey, N; Spliet, WG; Wulffraat, NM1
Saksena, S; Tandon, RK1
Attar, A; Aubertin, JM; Bécheur, H; Bloch, F; Charton-Bain, MC; Chatellier, G; Dall'osto, H; Petite, JP1
Groen, AK; Offerhaus, JJ; Ottenhoff, R; Oude Elferink, RP; Tytgat, GN; van den Bergh Weerman, MA; van Nieuwerk, CM; van Wijland, M1
Balistreri, WF1
Ashby, D; Cheng, K; Smyth, R2
Glaumann, H; Lindblad, A; Strandvik, B1
Doss, MO; Frank, M; Gross, U1
Battezzati, PM; Colombo, C; Podda, M; Strazzabosco, M1
Berenguer Lapuerta, J; Pérez-Aguilar, F1
Benz, C; Sauer, P; Stiehl, A1
García, N; Martí-Climent, JM; Medina, JF; Peñuelas, I; Prieto, J; Richter, JA1
Graziadei, IW; Trauner, M1
Battezzati, PM; Castellani, MR; Colombo, C; Comi, S; Crosignani, A; Giunta, A; Melzi, ML1
Bernard, O; Estournet-Mathiaud, B; Fabre, M; Grangeponte, MC; Labrune, P; Maurage, C; Rambaud, C; Trioche, P1
Kowdley, KV1
Carpenter, HA; Czaja, AJ; Moore, SB; Santrach, PJ1
Aragione, N; Franzese, A; Iannucci, MP; Vajro, P; Valerio, G1
Sokol, RJ1
Kumar, D; Tandon, RK1
Economou, H; Fotoulaki, M; Galli-Tsinopoulou, A; Nousia-Arvanitakis, S; Xefteri, M1
Gish, RG; Mason, A1
Gores, GJ; Lazaridis, KN; Lindor, KD1
Aldini, R; Azzaroli, F; Montagnani, M; Piazza, F; Roda, A; Roda, E; Russo, C1
Anan'eva, NP; Drondina, AK; Nikitina, TS; Reĭzis, AR; Stulov, AP1
Angulo, P1
Btaiche, IF; Khalidi, N1
Chayama, K; Tazuma, S1
Aoki, T; Araki, H; Date, S; Fujito, A; Imada, N; Imaide, Y; Iwamoto, N; Kamoi, K; Kitamori, T; Kitamura, K; Kojima, M; Mikami, K; Miki, T; Miyashita, H; Nakao, M; Ohe, H; Saitoh, M; Takada, H; Tanaka, S; Uchida, M; Ukimura, O1
Olsson, R1
Tangedahl, T1
Guma, C; Viola, L1
Assaisso, M; Battezzati, PM; Colombo, C; Crosignani, A; Giunta, A; Podda, M; Setchell, KD; Zimmer-Nechemias, L1
Erlinger, S1
Buongiorno, G; Guerra, V; Manghisi, OG; Misciagna, G; Quaranta, GM1
Apostolo, MG; Assaisso, M; Bottani, P; Colombo, C; Roman, B1
Lerner, A; Rivlin, J1
Fisher, LD; Fried, RH; McDonald, GB; Murakami, CS; Sullivan, KM; Willson, RA1
Assaisso, ML; Balistreri, WF; Castellani, MR; Colombo, C; Giunta, A; Seregni, E1
Tanner, MS1
Egestad, B; Marschall, HU; Matern, H; Matern, S; Sjövall, J; Wietholtz, H1
Cho, HM; Choi, SW; Chung, KW; Han, JH; Kim, BS; Lim, KT; Park, DH; Seo, EJ; Sun, HS1
de Caestecker, JS; Jazrawi, RP; Northfield, TC; Petroni, ML1
Beuers, U; Fischer, S; Paumgartner, G; Spengler, U1
Irifune, H; Nonaka, S; Tsukazaki, N; Watanabe, M1
Heuman, DM; Hylemon, PB; McCall, J; Mills, AS; Pandak, WM; Vlahcevic, ZR1
van Berge Henegouwen, GP; van Erpecum, KJ1
Berenson, MM; Garcia-Marin, JJ; Welch, V1
Berenson, MM; Bjorkman, DJ; Gunther, C; Samowitz, WS1
Colombo, C; Nakagawa, M; Setchell, KD1
Colombo, C; Crosignani, A; Curcio, L; Giunta, A; Podda, M; Roda, A; Ronchi, M; Setchell, KD1
Bäcker, U; Doss, MO; Meessen, D; Schmidt, FW; Wagner, S; Wittekind, C1
Hayakawa, T; Hoshino, M; Katagiri, K; Kawamura, Y; Miyani, M; Nakai, T; Ohnishi, H; Shiraka, S; Takeshima, A; Tsukada, K1
Ban, N; Kawasaki, T; Kimura, T; Moriyasu, F; Nakamura, T; Ono, S; Tamada, T; Uchino, H; Yamashita, Y1
Ishizaki, T; Kubota, K; Makino, I; Nakagawa, S; Shinozaki, K; Yamaguchi, A; Yamaoka, K1
Cohen, BI; Hagey, LR; Hofmann, AF; Mosbach, EH; Rothschild, MA; Stenger, RJ; Yoon, YB1
Goszcz, A1
Luciani, A; Massari, M; Montanari, P; Nora, A; Zandomeneghi, R1

Reviews

87 review(s) available for ursodeoxycholic acid and Liver Dysfunction

ArticleYear
Primary Biliary Cholangitis in Males: Pathogenesis, Clinical Presentation, and Prognosis.
    Clinics in liver disease, 2022, Volume: 26, Issue:4

    Topics: Cholangitis; Cholestasis; Female; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Male; Prognosis; Ursodeoxycholic Acid

2022
Ulcerative colitis complicated by primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome: a case report and literature review.
    Frontiers in immunology, 2023, Volume: 14

    Topics: Adult; Cholangitis, Sclerosing; Colitis, Ulcerative; Connective Tissue Diseases; Hepatitis, Autoimmune; Humans; Liver Diseases; Male; Syndrome; Ursodeoxycholic Acid

2023
Current Treatment Options for Cystic Fibrosis-Related Liver Disease.
    International journal of molecular sciences, 2020, Nov-14, Volume: 21, Issue:22

    Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Liver Diseases; Ursodeoxycholic Acid

2020
[Chronic cholestatic liver diseases : Differential diagnosis, pathogenesis and current treatment in adults].
    Der Internist, 2017, Volume: 58, Issue:8

    Topics: Adult; Bezafibrate; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholestasis; Diagnosis, Differential; Humans; Liver Diseases; Ursodeoxycholic Acid

2017
Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease.
    Current opinion in pulmonary medicine, 2017, Volume: 23, Issue:6

    Topics: Aftercare; Aminophenols; Aminopyridines; Benzodioxoles; Chloride Channel Agonists; Cholagogues and Choleretics; Cystic Fibrosis; Drug Combinations; Elasticity Imaging Techniques; Humans; Liver Diseases; Liver Transplantation; Quinolones; Ursodeoxycholic Acid

2017
Ursodeoxycholic acid for cystic fibrosis-related liver disease.
    The Cochrane database of systematic reviews, 2017, 09-11, Volume: 9

    Topics: Adolescent; Adult; Bile; Child; Child, Preschool; Cholagogues and Choleretics; Chronic Disease; Cystic Fibrosis; Humans; Liver; Liver Diseases; Nutritional Status; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid

2017
Low-Phospholipid Associated Cholelithiasis (LPAC) syndrome: A synthetic review.
    Journal of visceral surgery, 2019, Volume: 156, Issue:4

    Topics: Adult; Age Factors; ATP Binding Cassette Transporter, Subfamily B; Bile; Bile Duct Neoplasms; Cholagogues and Choleretics; Cholangiocarcinoma; Cholangitis; Cholangitis, Sclerosing; Cholecystectomy; Cholelithiasis; Codon, Nonsense; Diagnosis, Differential; Female; Gallstones; Humans; Lithiasis; Liver Abscess; Liver Cirrhosis, Biliary; Liver Diseases; Mutation; Phosphatidylcholines; Pregnancy; Pregnancy Complications; Recurrence; Syndrome; Ultrasonography; Ursodeoxycholic Acid

2019
Hepatic Manifestations of Cystic Fibrosis.
    Clinics in liver disease, 2019, Volume: 23, Issue:2

    Topics: Cholagogues and Choleretics; Cystic Fibrosis; Diagnosis, Differential; Humans; Hypertension, Portal; Liver Diseases; Liver Transplantation; Ursodeoxycholic Acid

2019
Sarcoidosis and the Liver.
    Clinics in liver disease, 2019, Volume: 23, Issue:2

    Topics: Adrenal Cortex Hormones; Cholagogues and Choleretics; Diagnosis, Differential; Humans; Liver Diseases; Liver Transplantation; Sarcoidosis; Ursodeoxycholic Acid

2019
UDCA, NorUDCA, and TUDCA in Liver Diseases: A Review of Their Mechanisms of Action and Clinical Applications.
    Handbook of experimental pharmacology, 2019, Volume: 256

    Topics: Bile Acids and Salts; Cholestasis; Humans; Liver; Liver Diseases; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid

2019
[Review of overlap syndromes in autoimmune liver diseases. Diagnostic and therapeutic difficulties].
    Orvosi hetilap, 2013, Jun-16, Volume: 154, Issue:24

    Topics: Adrenal Cortex Hormones; Autoantibodies; Autoimmunity; Cholangitis, Sclerosing; Diagnosis, Differential; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Diseases; Syndrome; Ursodeoxycholic Acid

2013
The liver in pediatric gastrointestinal disease.
    Journal of pediatric gastroenterology and nutrition, 2014, Volume: 59, Issue:3

    Topics: Adolescent; Antibodies, Monoclonal; Azathioprine; Celiac Disease; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cystic Fibrosis; Humans; Infant; Inflammatory Bowel Diseases; Infliximab; Liver Diseases; Liver Function Tests; Mercaptopurine; Methotrexate; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid

2014
Ursodeoxycholic acid for cystic fibrosis-related liver disease.
    The Cochrane database of systematic reviews, 2014, Dec-15, Issue:12

    Topics: Adolescent; Adult; Bile; Child; Child, Preschool; Cholagogues and Choleretics; Chronic Disease; Cystic Fibrosis; Humans; Liver; Liver Diseases; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid

2014
[New aspects of pharmacological effects of ursodeoxycholic acid].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2014, Issue:8

    Topics: Biliary Tract Diseases; Cholagogues and Choleretics; Humans; Liver Diseases; Treatment Outcome; Ursodeoxycholic Acid

2014
Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic Disorders.
    Digestive diseases (Basel, Switzerland), 2015, Volume: 33, Issue:3

    Topics: Animals; Bile Duct Diseases; Humans; Liver Diseases; Metabolic Diseases; Signal Transduction; Ursodeoxycholic Acid

2015
Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2016, Volume: 48, Issue:3

    Topics: Child; Child, Preschool; Cholagogues and Choleretics; Cholestasis; Fat Emulsions, Intravenous; Fatty Acids, Omega-3; Fish Oils; Humans; Infant; Infant, Newborn; Liver Diseases; Parenteral Nutrition; Soybean Oil; Ursodeoxycholic Acid

2016
AISF position paper on liver disease and pregnancy.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2016, Volume: 48, Issue:2

    Topics: Adrenal Cortex Hormones; Antihypertensive Agents; Budd-Chiari Syndrome; Calcium Channel Blockers; Cholagogues and Choleretics; Cholelithiasis; Cholestasis, Intrahepatic; Eclampsia; Fatty Liver; Female; Fluid Therapy; HELLP Syndrome; Hepatitis, Viral, Human; Humans; Hyperemesis Gravidarum; Italy; Liver Diseases; Magnesium Sulfate; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Societies, Medical; Thiamine; Ursodeoxycholic Acid; Viral Hepatitis Vaccines; Vitamin B Complex

2016
FXR Agonists: From Bench to Bedside, a Guide for Clinicians.
    Digestive diseases and sciences, 2016, Volume: 61, Issue:12

    Topics: Animals; Azepines; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholestasis; Drug Evaluation, Preclinical; Gastrointestinal Agents; Hepatitis, Autoimmune; Humans; Hypertension, Portal; Indoles; Isoxazoles; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Diseases; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid

2016
Nor-Ursodeoxycholic Acid as a Novel Therapeutic Approach for Cholestatic and Metabolic Liver Diseases.
    Digestive diseases (Basel, Switzerland), 2017, Volume: 35, Issue:3

    Topics: Animals; Cholestasis; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Liver Diseases; Metabolic Diseases; Ursodeoxycholic Acid

2017
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases.
    Current clinical pharmacology, 2007, Volume: 2, Issue:2

    Topics: Animals; Bile Acids and Salts; Biological Transport, Active; Child; Cholagogues and Choleretics; Cholestasis; Female; Humans; Liver Diseases; Pregnancy; Ursodeoxycholic Acid

2007
[Parenteral nutrition-associated liver disease].
    Nutricion hospitalaria, 2008, Volume: 23 Suppl 2

    Topics: Age Factors; Cholagogues and Choleretics; Cholestasis; Enteral Nutrition; Humans; Infant, Newborn; Infant, Premature; Liver Diseases; Parenteral Nutrition; Risk Factors; Short Bowel Syndrome; Time Factors; Ursodeoxycholic Acid

2008
[Liver diseases in pregnancy].
    Deutsche medizinische Wochenschrift (1946), 2008, Volume: 133, Issue:44

    Topics: Cholagogues and Choleretics; Cholestasis, Intrahepatic; Delivery, Obstetric; Fatty Liver; Female; HELLP Syndrome; Humans; Hyperemesis Gravidarum; Liver Diseases; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid

2008
Apoptotic signaling pathways as a target for the treatment of liver diseases.
    Mini reviews in medicinal chemistry, 2008, Volume: 8, Issue:14

    Topics: Animals; Apoptosis; Atorvastatin; Gliotoxin; Heptanoic Acids; Humans; Liver Diseases; Molecular Conformation; Pyrroles; Signal Transduction; Ursodeoxycholic Acid

2008
The chronic liver disease in patients with short bowel syndrome: etiology and treatment.
    Minerva pediatrica, 2009, Volume: 61, Issue:3

    Topics: Anti-Bacterial Agents; Child; Cholagogues and Choleretics; Cholestasis; Drug Therapy, Combination; Enteral Nutrition; Evidence-Based Medicine; Humans; Infant, Newborn; Infant, Premature; Intestine, Small; Liver Diseases; Parenteral Nutrition; Parenteral Nutrition, Home; Practice Guidelines as Topic; Prognosis; Risk Factors; Sepsis; Short Bowel Syndrome; Treatment Outcome; Ursodeoxycholic Acid

2009
Therapeutic use of cytoprotective agents in canine and feline hepatobiliary disease.
    The Veterinary clinics of North America. Small animal practice, 2009, Volume: 39, Issue:3

    Topics: Acetylcysteine; Animals; Antioxidants; Biliary Tract Diseases; Cat Diseases; Cats; Cholagogues and Choleretics; Cryoprotective Agents; Dog Diseases; Dogs; Free Radical Scavengers; Liver Diseases; S-Adenosylmethionine; Silymarin; Ursodeoxycholic Acid; Vitamin E

2009
Autoimmune liver disease for the non-specialist.
    BMJ (Clinical research ed.), 2009, Sep-08, Volume: 339

    Topics: Autoimmune Diseases; Cholagogues and Choleretics; Family Practice; Humans; Liver Diseases; Nurse Clinicians; Nurse's Role; Ursodeoxycholic Acid

2009
Liver disease associated with canalicular transport defects: current and future therapies.
    Journal of hepatology, 2010, Volume: 52, Issue:2

    Topics: Adenosine Triphosphatases; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP Binding Cassette Transporter, Subfamily G, Member 5; ATP Binding Cassette Transporter, Subfamily G, Member 8; ATP-Binding Cassette Transporters; Bile; Bile Canaliculi; Biliary Tract Surgical Procedures; Biological Transport, Active; Cholestyramine Resin; Genetic Therapy; Humans; Lipoproteins; Liver Diseases; Liver Transplantation; Models, Biological; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Mutation; Rifampin; Ursodeoxycholic Acid

2010
The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.
    Seminars in liver disease, 2010, Volume: 30, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Cholestasis, Intrahepatic; Female; Genes, MDR; Genetic Predisposition to Disease; Humans; Infant, Newborn; Jaundice, Neonatal; Liver Diseases; Liver Transplantation; Mutation; Mutation, Missense; Phenotype; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid

2010
Targeting the p53 pathway of apoptosis.
    Current pharmaceutical design, 2010, Volume: 16, Issue:22

    Topics: Animals; Apoptosis; Cholagogues and Choleretics; Drug Design; Humans; Liver Diseases; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53; Ursodeoxycholic Acid

2010
Cystic fibrosis-associated liver disease.
    Best practice & research. Clinical gastroenterology, 2010, Volume: 24, Issue:5

    Topics: Animals; Cholagogues and Choleretics; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Portasystemic Shunt, Transjugular Intrahepatic; Ursodeoxycholic Acid

2010
Bile acids for primary sclerosing cholangitis.
    The Cochrane database of systematic reviews, 2011, Jan-19, Issue:1

    Topics: Cholagogues and Choleretics; Cholangitis, Sclerosing; Humans; Liver Diseases; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid

2011
Therapeutic approach of hepatic sarcoidosis.
    Current opinion in pulmonary medicine, 2012, Volume: 18, Issue:5

    Topics: Antioxidants; Humans; Liver Diseases; Prednisone; Sarcoidosis; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid

2012
[The substantiation of UDCA usage in functional disorders of biliary tract].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2011, Issue:9

    Topics: Animals; Gallbladder Diseases; Humans; Liver Diseases; Ursodeoxycholic Acid

2011
Sarcoidosis of the liver: to treat or not to treat?
    The Netherlands journal of medicine, 2012, Volume: 70, Issue:8

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Cholagogues and Choleretics; Fatigue; Female; Humans; Liver; Liver Diseases; Male; Middle Aged; Prednisolone; Pruritus; Sarcoidosis; Treatment Outcome; Ursodeoxycholic Acid

2012
Ursodeoxycholic acid for cystic fibrosis-related liver disease.
    The Cochrane database of systematic reviews, 2012, Oct-17, Volume: 10

    Topics: Cholagogues and Choleretics; Chronic Disease; Cystic Fibrosis; Humans; Liver Diseases; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid

2012
Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.
    Hepatology (Baltimore, Md.), 2002, Volume: 36, Issue:3

    Topics: Cholagogues and Choleretics; Cholestasis; Humans; Liver Diseases; Ursodeoxycholic Acid

2002
[Extraintestinal manifestations].
    Zeitschrift fur Gastroenterologie, 2003, Volume: 41, Issue:1

    Topics: Amyloidosis; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Cholelithiasis; Cohort Studies; Controlled Clinical Trials as Topic; Crohn Disease; Cross-Sectional Studies; Drug Therapy, Combination; Eye Diseases; Humans; Immunosuppressive Agents; Joint Diseases; Kidney Calculi; Kidney Diseases; Liver Diseases; Longitudinal Studies; Lung Diseases; Nervous System Diseases; Osteoporosis; Pancreatitis; Placebos; Prospective Studies; Retrospective Studies; Risk; Risk Factors; Skin Diseases; Thromboembolism; Ursodeoxycholic Acid

2003
Review article: pruritus in cholestatic and other liver diseases.
    Alimentary pharmacology & therapeutics, 2003, Apr-01, Volume: 17, Issue:7

    Topics: Anion Exchange Resins; Antipruritics; Cholagogues and Choleretics; Humans; Liver Diseases; Narcotic Antagonists; Ondansetron; Pruritus; Rifampin; Ursodeoxycholic Acid

2003
[Therapeutic options for drug induced liver injury: the efficacy of UDCA based on EBM].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2003, Volume: 100, Issue:6

    Topics: Androgen Antagonists; Animals; Chemical and Drug Induced Liver Injury; Evidence-Based Medicine; Flutamide; Liver Diseases; Rats; Ursodeoxycholic Acid

2003
Systematic review: ursodeoxycholic acid--adverse effects and drug interactions.
    Alimentary pharmacology & therapeutics, 2003, Nov-15, Volume: 18, Issue:10

    Topics: Cholagogues and Choleretics; Chronic Disease; Drug Interactions; Female; Humans; Liver Diseases; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid

2003
[Autoimmune liver disease: diagnosis and therapy].
    Zeitschrift fur Gastroenterologie, 2004, Volume: 42, Issue:1

    Topics: Adult; Autoantibodies; Autoimmune Diseases; Azathioprine; Biopsy; Child; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Diagnosis, Differential; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis, Autoimmune; Humans; Immunoassay; Immunosuppression Therapy; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prognosis; Ultrasonography; Ursodeoxycholic Acid

2004
Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease.
    Clinics in liver disease, 2004, Volume: 8, Issue:1

    Topics: Cholestasis; Enterohepatic Circulation; Humans; Liver Diseases; Treatment Outcome; Ursodeoxycholic Acid

2004
[Hepatitis 2004: an update].
    Therapeutische Umschau. Revue therapeutique, 2004, Volume: 61, Issue:8

    Topics: Antiviral Agents; Biopsy; Cholagogues and Choleretics; Clinical Enzyme Tests; Diagnosis, Differential; Hepatitis; Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis D; Hepatitis E; Hepatitis, Alcoholic; Humans; Laparoscopy; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Physical Examination; Ultrasonography; Ursodeoxycholic Acid; Weight Loss

2004
Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis.
    Digestive diseases and sciences, 2005, Volume: 50, Issue:1

    Topics: Adult; Cholagogues and Choleretics; Female; Granuloma; Humans; Liver Diseases; Sarcoidosis; Treatment Outcome; Ursodeoxycholic Acid

2005
Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis.
    Nature clinical practice. Gastroenterology & hepatology, 2006, Volume: 3, Issue:10

    Topics: Adrenal Cortex Hormones; Bacterial Infections; Bile; Bile Ducts; Cholestasis; Cytokines; Humans; Liver; Liver Diseases; Liver Transplantation; Nitric Oxide; Sepsis; Ursodeoxycholic Acid

2006
Hepatology may have problems with putative surrogate outcome measures.
    Journal of hepatology, 2007, Volume: 46, Issue:4

    Topics: Antiviral Agents; Bilirubin; Biomarkers; Cholagogues and Choleretics; Gastroenterology; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferons; Liver Cirrhosis, Biliary; Liver Diseases; Outcome Assessment, Health Care; Reproducibility of Results; Ribavirin; Ursodeoxycholic Acid; Viral Load

2007
Parenteral nutrition related hepato-biliary disease in adults.
    Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, 2007, Volume: 32, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Biliary Tract Diseases; Cholestasis; Fatty Liver; Gallstones; Hepatitis; Humans; Intestines; Liver Diseases; Liver Transplantation; Parenteral Nutrition, Total; Ursodeoxycholic Acid

2007
Managing liver dysfunction in parenteral nutrition.
    The Proceedings of the Nutrition Society, 2007, Volume: 66, Issue:4

    Topics: Anti-Bacterial Agents; Cholestasis; Enteral Nutrition; Humans; Liver Diseases; Parenteral Nutrition; Risk Factors; Sepsis; Ursodeoxycholic Acid

2007
[Pathogenesis and progress in treatment of neonatal total parenteral nutrition-associated cholestasis].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2008, Volume: 46, Issue:1

    Topics: Cholestasis; Female; Humans; Liver Diseases; Male; Neonatology; Parenteral Nutrition, Total; S-Adenosylmethionine; Ursodeoxycholic Acid

2008
Systemic spill-over of bile acids.
    European journal of clinical investigation, 1983, Volume: 13, Issue:6

    Topics: Bile Acids and Salts; Enterohepatic Circulation; Humans; Kinetics; Liver Diseases; Ursodeoxycholic Acid

1983
[Bile acids in liver diseases--current indications].
    Therapeutische Umschau. Revue therapeutique, 1995, Volume: 52, Issue:10

    Topics: Bile Acids and Salts; Biliary Atresia; Child; Cholangitis, Sclerosing; Female; Hepatitis; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Male; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid

1995
Liver disease in cystic fibrosis.
    Archives of disease in childhood, 1995, Volume: 72, Issue:4

    Topics: Adolescent; Adult; Bile Duct Diseases; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Susceptibility; Genetic Therapy; Humans; Liver Diseases; Membrane Proteins; Ursodeoxycholic Acid

1995
[Various problems in therapy and prognosis of drug-induced liver diseases].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1995, Feb-10, Volume: 84, Issue:2

    Topics: Chemical and Drug Induced Liver Injury; Diet, Fat-Restricted; Drug-Related Side Effects and Adverse Reactions; Humans; Liver Diseases; Phenobarbital; Prednisolone; Prognosis; Ursodeoxycholic Acid

1995
Pharmacology of ursodeoxycholic acid, an enterohepatic drug.
    Scandinavian journal of gastroenterology. Supplement, 1994, Volume: 204

    Topics: Bile Acids and Salts; Cholestasis; Humans; Liver Diseases; Ursodeoxycholic Acid

1994
Cystic fibrosis. Is treatment with ursodeoxycholic acid of value?
    Scandinavian journal of gastroenterology. Supplement, 1994, Volume: 204

    Topics: Animals; Clinical Trials as Topic; Cystic Fibrosis; Gallbladder Diseases; Humans; Liver Diseases; Liver Function Tests; Ursodeoxycholic Acid

1994
[Bile acids in therapy of liver diseases].
    Der Internist, 1994, Volume: 35, Issue:12

    Topics: Chronic Disease; Dose-Response Relationship, Drug; Humans; Liver Diseases; Ursodeoxycholic Acid

1994
[Ursodeoxycholic acid: hope in the treatment of liver diseases].
    Revue medicale de la Suisse romande, 1994, Volume: 114, Issue:9

    Topics: Animals; Cholangitis, Sclerosing; Cholelithiasis; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Postcholecystectomy Syndrome; Rats; Ursodeoxycholic Acid

1994
Hepatoprotection by hydrophilic bile salts.
    Journal of hepatology, 1994, Volume: 21, Issue:2

    Topics: Bile Acids and Salts; Cholangitis; Humans; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid

1994
Therapy with ursodeoxycholic acid in cholestatic liver disease.
    Scandinavian journal of gastroenterology. Supplement, 1993, Volume: 200

    Topics: Cholangitis, Sclerosing; Cholestasis; Cholestasis, Intrahepatic; Cystic Fibrosis; Female; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Postoperative Care; Pregnancy; Pregnancy Complications; Recurrence; Ursodeoxycholic Acid

1993
Ursodiol for hepatobiliary disorders.
    Annals of internal medicine, 1994, Aug-01, Volume: 121, Issue:3

    Topics: Animals; Cholelithiasis; Humans; Liver Diseases; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid

1994
The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease.
    The Gastroenterologist, 1994, Volume: 2, Issue:1

    Topics: Alagille Syndrome; Biliary Atresia; Cholangitis, Sclerosing; Cholestasis; Chronic Disease; Cystic Fibrosis; Graft vs Host Disease; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid

1994
Ursodeoxycholic acid in the treatment of chronic liver disease.
    The American journal of gastroenterology, 1994, Volume: 89, Issue:9

    Topics: Chronic Disease; Clinical Trials as Topic; Cystic Fibrosis; Hepatitis, Chronic; Humans; Liver Diseases; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid

1994
Rationale for therapy with ursodeoxycholic acid in patients with cholestatic liver disease.
    The Netherlands journal of medicine, 1993, Volume: 43, Issue:5-6

    Topics: Bile Acids and Salts; Cholestasis; Enterohepatic Circulation; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid

1993
Oral bile acids in cystic fibrosis-associated liver disease.
    Journal of the Royal Society of Medicine, 1994, Volume: 87 Suppl 21

    Topics: Administration, Oral; Clinical Trials as Topic; Cystic Fibrosis; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Liver Diseases; Pilot Projects; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid

1994
[Bile acids in the therapy of chronic liver diseases].
    Recenti progressi in medicina, 1993, Volume: 84, Issue:3

    Topics: Chronic Disease; Hepatitis, Chronic; Humans; Liver Diseases; Ursodeoxycholic Acid

1993
Clinical pharmacokinetics of therapeutic bile acids.
    Clinical pharmacokinetics, 1996, Volume: 30, Issue:5

    Topics: Absorption; Administration, Oral; Bile Acids and Salts; Chenodeoxycholic Acid; Cholagogues and Choleretics; Chronic Disease; Humans; Injections, Intravenous; Liver; Liver Diseases; Ursodeoxycholic Acid

1996
[New gastroenterological prospects of ursodeoxycholic acid].
    Klinicheskaia meditsina, 1996, Volume: 74, Issue:4

    Topics: Bile; Dose-Response Relationship, Drug; Gallbladder Diseases; Gastrointestinal Agents; Humans; Liver Diseases; Treatment Outcome; Ursodeoxycholic Acid

1996
Ursodeoxycholic acid in the treatment of liver diseases.
    Postgraduate medical journal, 1997, Volume: 73, Issue:856

    Topics: Biliary Tract Diseases; Cholagogues and Choleretics; Chronic Disease; Female; Graft Rejection; Graft vs Host Disease; Humans; Liver Diseases; Liver Transplantation; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid

1997
Bile acid therapy in pediatric hepatobiliary disease: the role of ursodeoxycholic acid.
    Journal of pediatric gastroenterology and nutrition, 1997, Volume: 24, Issue:5

    Topics: Adolescent; Adult; Bile Acids and Salts; Biliary Tract Diseases; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Liver Diseases; Male; Pregnancy; Ursodeoxycholic Acid

1997
Ursodeoxycholic acid in cystic fibrosis-related liver disease: a systematic review.
    Journal of the Royal Society of Medicine, 1997, Volume: 90 Suppl 31

    Topics: Cholagogues and Choleretics; Cystic Fibrosis; Humans; Liver Diseases; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid

1997
Liver and biliary problems in cystic fibrosis.
    Seminars in liver disease, 1998, Volume: 18, Issue:3

    Topics: Child; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Diagnosis, Differential; Humans; Liver; Liver Diseases; Prognosis; Ursodeoxycholic Acid

1998
[Hepatobiliary disease in cystic fibrosis].
    Medicina clinica, 1998, Sep-19, Volume: 111, Issue:8

    Topics: Bile Duct Diseases; Biomarkers; Cholagogues and Choleretics; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Liver Diseases; Ursodeoxycholic Acid

1998
Mechanism of hepatoprotective action of bile salts in liver disease.
    Gastroenterology clinics of North America, 1999, Volume: 28, Issue:1

    Topics: Animals; Cell Death; Cholagogues and Choleretics; Humans; Lipid Peroxidation; Liver; Liver Circulation; Liver Diseases; Ursodeoxycholic Acid

1999
Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:8

    Topics: Animals; Cholagogues and Choleretics; Cholestasis, Intrahepatic; Chronic Disease; Female; Humans; Liver Diseases; Pregnancy; Ursodeoxycholic Acid

1999
Ursodeoxycholic acid therapy in hepatobiliary disease.
    The American journal of medicine, 2000, Apr-15, Volume: 108, Issue:6

    Topics: Biliary Tract Diseases; Bone Marrow Transplantation; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Chronic Disease; Cystic Fibrosis; Female; Graft Rejection; Graft vs Host Disease; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Parenteral Nutrition, Total; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid

2000
Ursodeoxycholic acid for cystic fibrosis-related liver disease.
    The Cochrane database of systematic reviews, 2000, Issue:2

    Topics: Cholagogues and Choleretics; Cystic Fibrosis; Humans; Liver Diseases; Ursodeoxycholic Acid

2000
Use of ursodeoxycholic acid in liver diseases.
    Journal of gastroenterology and hepatology, 2001, Volume: 16, Issue:1

    Topics: Cholagogues and Choleretics; Chronic Disease; Humans; Liver Diseases; Ursodeoxycholic Acid

2001
Autoimmune liver disease. Current standards, future directions.
    Clinics in liver disease, 2001, Volume: 5, Issue:2

    Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Azathioprine; Cholagogues and Choleretics; Cholangitis, Sclerosing; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Prednisone; Prognosis; Ursodeoxycholic Acid

2001
Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'.
    Journal of hepatology, 2001, Volume: 35, Issue:1

    Topics: Animals; Bile Duct Diseases; Chemical Phenomena; Chemistry, Physical; Humans; Liver Diseases; Ursodeoxycholic Acid

2001
Use of ursodeoxycholic acid in patients with liver disease.
    Current gastroenterology reports, 2002, Volume: 4, Issue:1

    Topics: Cholagogues and Choleretics; Disease-Free Survival; Humans; Liver Diseases; Ursodeoxycholic Acid

2002
Parenteral nutrition-associated liver complications in children.
    Pharmacotherapy, 2002, Volume: 22, Issue:2

    Topics: Alkaline Phosphatase; Anti-Bacterial Agents; Bilirubin; Carnitine; Child; Cholestasis; gamma-Glutamyltransferase; Humans; Liver; Liver Diseases; Parenteral Nutrition; Sepsis; Sincalide; Taurine; Ursodeoxycholic Acid

2002
[Ursodeoxycholic acid in the treatment of chronic cholestatic liver disease. Documented delay in disease progress inspires hope].
    Lakartidningen, 2002, Mar-21, Volume: 99, Issue:12

    Topics: Cholagogues and Choleretics; Cholestasis, Intrahepatic; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid

2002
Dissolution of gallstones--when and how?
    The Surgical clinics of North America, 1979, Volume: 59, Issue:5

    Topics: Bile; Chenodeoxycholic Acid; Cholecystography; Cholelithiasis; Drug Administration Schedule; Female; Humans; Liver Diseases; Obesity; Pregnancy; Ursodeoxycholic Acid

1979
Liver disease in cystic fibrosis.
    The Netherlands journal of medicine, 1992, Volume: 41, Issue:3-4

    Topics: Cystic Fibrosis; Humans; Liver Diseases; Ursodeoxycholic Acid

1992
[New aspects of cystic fibrosis liver disease].
    Harefuah, 1992, May-01, Volume: 122, Issue:9

    Topics: Adolescent; Cystic Fibrosis; Humans; Liver Diseases; Male; Ursodeoxycholic Acid

1992
Ursodeoxycholic acid in chronic liver disease.
    Gut, 1991, Volume: 32, Issue:9

    Topics: Animals; Cholestasis; Chronic Disease; Hepatitis; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid

1991
[Bile acid therapy; new hope for patients with chronic liver diseases].
    Nederlands tijdschrift voor geneeskunde, 1991, Apr-20, Volume: 135, Issue:16

    Topics: Cholangitis, Sclerosing; Cholelithiasis; Chronic Disease; Hepatitis, Chronic; Humans; Infant, Newborn; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Ursodeoxycholic Acid

1991

Trials

17 trial(s) available for ursodeoxycholic acid and Liver Dysfunction

ArticleYear
Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2020, Volume: 18, Issue:5

    Topics: Chenodeoxycholic Acid; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid

2020
Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction.
    Scientific reports, 2018, 08-08, Volume: 8, Issue:1

    Topics: Adult; Antioxidants; Humans; Liver; Liver Diseases; Male; Microbiota; MicroRNAs; Phenylalanine; Tyrosine; Ursodeoxycholic Acid; Vitamin E; Young Adult

2018
Ursodeoxycholic acid in advanced polycystic liver disease: A phase 2 multicenter randomized controlled trial.
    Journal of hepatology, 2016, Volume: 65, Issue:3

    Topics: Cysts; Humans; Liver Diseases; Polycystic Kidney, Autosomal Dominant; Quality of Life; Ursodeoxycholic Acid

2016
A controlled trial of erythromycin and UDCA in premature infants during parenteral nutrition in minimizing feeding intolerance and liver function abnormalities.
    Journal of perinatology : official journal of the California Perinatal Association, 2012, Volume: 32, Issue:2

    Topics: Administration, Oral; Child Development; Cholestasis; Double-Blind Method; Erythromycin; Feeding and Eating Disorders; Feeding Behavior; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Liver Diseases; Liver Function Tests; Male; Parenteral Nutrition; Prospective Studies; Risk Assessment; Ursodeoxycholic Acid; Weight Gain

2012
Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation.
    Blood, 2002, Sep-15, Volume: 100, Issue:6

    Topics: Adolescent; Adult; Alanine Transaminase; Bilirubin; Child; Child, Preschool; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Infant; Liver Diseases; Male; Middle Aged; Prospective Studies; Survival Analysis; Transplantation, Homologous; Ursodeoxycholic Acid

2002
Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.
    Transplantation, 2007, Jun-27, Volume: 83, Issue:12

    Topics: Adult; Aged; Cholagogues and Choleretics; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Male; Middle Aged; Patient Compliance; Placebos; Prednisone; Safety; Ursodeoxycholic Acid

2007
The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid.
    Liver international : official journal of the International Association for the Study of the Liver, 2007, Volume: 27, Issue:10

    Topics: Adolescent; Adult; Child; Cholagogues and Choleretics; Cystic Fibrosis; Disease Progression; Female; Follow-Up Studies; Humans; Hypertension, Portal; Liver Diseases; Liver Function Tests; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid

2007
Failure of ursodeoxycholic acid to prevent acute cellular rejection after liver transplantation.
    Journal of hepatology, 1995, Volume: 23, Issue:2

    Topics: Acute Disease; Cholagogues and Choleretics; Double-Blind Method; Female; Graft Rejection; Humans; Liver Diseases; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Ursodeoxycholic Acid

1995
Effect of a medium dose of ursodeoxycholic acid with or without taurine supplementation on the nutritional status of patients with cystic fibrosis: a randomized, placebo-controlled, crossover trial.
    Journal of pediatric gastroenterology and nutrition, 1994, Volume: 19, Issue:2

    Topics: Absorption; Adolescent; Adult; Bile Acids and Salts; Child; Cross-Over Studies; Cystic Fibrosis; Dietary Fats; Female; Humans; Liver Diseases; Male; Nutritional Status; Placebos; Prospective Studies; Taurine; Ursodeoxycholic Acid

1994
Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis.
    Hepatology (Baltimore, Md.), 1996, Volume: 23, Issue:6

    Topics: 5'-Nucleotidase; Adolescent; Adult; Child; Child, Preschool; Cystic Fibrosis; Double-Blind Method; Drug Therapy, Combination; Female; gamma-Glutamyltransferase; Gastrointestinal Agents; Humans; Liver Diseases; Male; Nutritional Status; Prealbumin; Taurine; Ursodeoxycholic Acid

1996
Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
    European journal of gastroenterology & hepatology, 1996, Volume: 8, Issue:5

    Topics: Adolescent; Adult; Bile Acids and Salts; Cholagogues and Choleretics; Cystic Fibrosis; Female; Humans; Liver Diseases; Male; Ursodeoxycholic Acid

1996
Effect of ursodeoxycholic acid on hypertransaminasaemia and bile acid composition in patients undergoing bone marrow transplantation--a double-blind randomized control study.
    The Italian journal of gastroenterology, 1996, Volume: 28, Issue:4

    Topics: Administration, Oral; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bile Acids and Salts; Bone Marrow Transplantation; Double-Blind Method; Feces; Female; Humans; Liver Diseases; Lymphocyte Depletion; Male; Ursodeoxycholic Acid

1996
A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease.
    Hepatology (Baltimore, Md.), 1998, Volume: 27, Issue:1

    Topics: Adolescent; Adult; Bile Acids and Salts; Child; Cystic Fibrosis; Female; Gas Chromatography-Mass Spectrometry; Humans; Liver; Liver Diseases; Liver Function Tests; Male; Prospective Studies; Spectrometry, Mass, Fast Atom Bombardment; Treatment Outcome; Ursodeoxycholic Acid

1998
Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children.
    The Journal of pediatrics, 2000, Volume: 136, Issue:6

    Topics: Child; Female; Humans; Liver Diseases; Male; Obesity; Ursodeoxycholic Acid

2000
Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study.
    Hepatology (Baltimore, Md.), 1992, Volume: 16, Issue:4

    Topics: Bile Acids and Salts; Cystic Fibrosis; Dose-Response Relationship, Drug; Duodenum; Enzymes; Humans; Liver; Liver Diseases; Ursodeoxycholic Acid

1992
Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver.
    Annals of internal medicine, 1992, Apr-15, Volume: 116, Issue:8

    Topics: Bilirubin; Cholestasis; Chronic Disease; Graft vs Host Disease; Humans; Liver Diseases; Ursodeoxycholic Acid

1992
A pharmacokinetic analysis of enterohepatic circulation of ursodeoxycholic acid, a drug with a high hepatic extraction but a small clearance.
    Research communications in chemical pathology and pharmacology, 1988, Volume: 62, Issue:2

    Topics: Administration, Oral; Adult; Aged; Deoxycholic Acid; Enterohepatic Circulation; Female; Humans; Injections, Intravenous; Liver; Liver Diseases; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Radioimmunoassay; Ursodeoxycholic Acid

1988

Other Studies

118 other study(ies) available for ursodeoxycholic acid and Liver Dysfunction

ArticleYear
Successful treatment of an infant with congenital bile acid synthesis disorder type 3 by ursodeoxycholic acid: a case report.
    Journal of medical case reports, 2022, Apr-07, Volume: 16, Issue:1

    Topics: Bile Acids and Salts; Humans; Infant; Liver; Liver Diseases; Male; Oxysterols; Ursodeoxycholic Acid

2022
Rolling stones: an instructive case of neonatal cholestasis.
    BMC pediatrics, 2022, 09-04, Volume: 22, Issue:1

    Topics: Biliary Atresia; Choledocholithiasis; Cholestasis; Humans; Hyperbilirubinemia; Infant; Infant, Newborn; Infant, Newborn, Diseases; Jaundice, Neonatal; Liver Diseases; Male; Ursodeoxycholic Acid

2022
Perinatal exposure to UDCA prevents neonatal cholestasis in Cyp2c70
    Pediatric research, 2023, Volume: 93, Issue:6

    Topics: Animals; Bile Acids and Salts; Cholestasis; Female; Humans; Infant, Newborn; Liver Diseases; Male; Mice; Pregnancy; Ursodeoxycholic Acid

2023
Development and validation of a primary sclerosing cholangitis-specific health-related quality of life instrument: CLDQ-PSC.
    Hepatology communications, 2023, 02-01, Volume: 7, Issue:2

    Topics: Cholangitis, Sclerosing; Female; Humans; Liver Cirrhosis; Liver Diseases; Male; Quality of Life; Surveys and Questionnaires; Ursodeoxycholic Acid

2023
Protective effect of ursodeoxycholic acid on COVID-19 in patients with chronic liver disease.
    Frontiers in cellular and infection microbiology, 2023, Volume: 13

    Topics: Cholagogues and Choleretics; COVID-19; COVID-19 Vaccines; Humans; Liver Diseases; SARS-CoV-2; Ursodeoxycholic Acid

2023
Ursodeoxycholic acid administration did not reduce susceptibility to SARS-CoV-2 infection in children.
    Liver international : official journal of the International Association for the Study of the Liver, 2023, Volume: 43, Issue:9

    Topics: Child; COVID-19; Hospitalization; Humans; Liver Diseases; SARS-CoV-2; Ursodeoxycholic Acid

2023
Bile acids and bilirubin effects on osteoblastic gene profile. Implications in the pathogenesis of osteoporosis in liver diseases.
    Gene, 2020, Jan-30, Volume: 725

    Topics: Apoptosis; Bile Acids and Salts; Bilirubin; Cell Line, Tumor; Cholestasis; Down-Regulation; Genetic Profile; Humans; Lithocholic Acid; Liver; Liver Diseases; Osteoblasts; Osteoporosis; Osteosarcoma; Up-Regulation; Ursodeoxycholic Acid

2020
Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease.
    Hepatology (Baltimore, Md.), 2021, Volume: 73, Issue:1

    Topics: Animals; Apoptosis; Bile Acids and Salts; Bile Ducts; Cell Proliferation; Cysts; Disease Models, Animal; Histone Deacetylase 6; Liver; Liver Diseases; Random Allocation; Rats; Synthetic Drugs; Ursodeoxycholic Acid

2021
Congenital erythropoietic protoporphyria and protoporphyric hepatopathy in a dog.
    Journal of the American Veterinary Medical Association, 2020, Dec-01, Volume: 257, Issue:11

    Topics: Animals; Bile; Dog Diseases; Dogs; Liver; Liver Diseases; Male; Protoporphyria, Erythropoietic; Ursodeoxycholic Acid

2020
Mefepronic acid is associated with a decrease in serum liver enzyme activities in dogs with suspected hepatopathy.
    Veterinary medicine and science, 2021, Volume: 7, Issue:5

    Topics: Animals; Dog Diseases; Dogs; Liver Diseases; Ursodeoxycholic Acid

2021
Omega-3 Polyunsaturated Fatty Acid: A Pharmaco-Nutraceutical Approach to Improve the Responsiveness to Ursodeoxycholic Acid.
    Nutrients, 2021, Jul-29, Volume: 13, Issue:8

    Topics: Apoptosis; Autoimmune Diseases; Bile Acids and Salts; Carcinoma, Hepatocellular; Caspase 3; Cholangitis, Sclerosing; Cholestanetriol 26-Monooxygenase; Cholestasis; Cholesterol 7-alpha-Hydroxylase; Dietary Supplements; Down-Regulation; Drug Therapy, Combination; Endoplasmic Reticulum Stress; Fatty Acids, Omega-3; Gene Expression; Hep G2 Cells; Humans; Inflammation; Liver; Liver Cirrhosis, Biliary; Liver Diseases; THP-1 Cells; Ursodeoxycholic Acid

2021
Hepatic actinomycosis with immunoglobulin G4-related liver disease: A case report.
    Medicine, 2018, Volume: 97, Issue:24

    Topics: Actinomycosis; Aged; Diagnosis, Differential; Granuloma, Plasma Cell; Humans; Immunoglobulin G; Liver; Liver Diseases; Male; Tomography, X-Ray Computed; Ursodeoxycholic Acid

2018
[In process].
    Medizinische Monatsschrift fur Pharmazeuten, 2017, Volume: 40, Issue:3

    Topics: Cholagogues and Choleretics; Gallbladder Diseases; Humans; Liver Diseases; Ursodeoxycholic Acid

2017
Pancreatic Cystosis and Intrahepatic Biliopathy in a Young Adult with Cystic Fibrosis.
    The Journal of pediatrics, 2018, Volume: 203

    Topics: Abdominal Pain; Adolescent; Biopsy; Cholagogues and Choleretics; Cholangiopancreatography, Magnetic Resonance; Cholangitis, Sclerosing; Constipation; Contraceptives, Oral; Cystic Fibrosis; Female; Humans; Jaundice; Liver; Liver Diseases; Lung Diseases; Ovarian Cysts; Pancreas; Pancreatic Cyst; Pruritus; Radiography, Abdominal; Tomography, X-Ray Computed; Ursodeoxycholic Acid; Weight Loss

2018
Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients.
    Hepatology (Baltimore, Md.), 2019, Volume: 69, Issue:4

    Topics: Adolescent; Child; Cystic Fibrosis; Female; France; Humans; Incidence; Liver Diseases; Male; Retrospective Studies; Risk Factors; Ursodeoxycholic Acid; Young Adult

2019
NorUDCA promotes degradation of α1-antitrypsin mutant Z protein by inducing autophagy through AMPK/ULK1 pathway.
    PloS one, 2018, Volume: 13, Issue:8

    Topics: Adenylate Kinase; alpha 1-Antitrypsin; Animals; Autophagy; Autophagy-Related Protein-1 Homolog; Disease Models, Animal; HeLa Cells; Humans; Intracellular Signaling Peptides and Proteins; Liver; Liver Diseases; Mice; Mutant Proteins; Proteolysis; RNA, Messenger; Signal Transduction; TOR Serine-Threonine Kinases; Ursodeoxycholic Acid

2018
Therapeutics Highlights from ILC 2018, the EASL annual congress.
    Clinics and research in hepatology and gastroenterology, 2018, Volume: 42, Issue:4

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Bezafibrate; Budesonide; CCR5 Receptor Antagonists; Congresses as Topic; Fibroblast Growth Factors; Gastrointestinal Agents; Humans; Imidazoles; Liver Diseases; Pyridazines; Sulfoxides; Uracil; Ursodeoxycholic Acid

2018
Diagnosis of primary biliary cholangitis in a "teen" male patient.
    Clinics and research in hepatology and gastroenterology, 2019, Volume: 43, Issue:2

    Topics: Age Factors; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Cholagogues and Choleretics; Cholangitis; Cholestasis, Intrahepatic; Humans; Liver Diseases; Male; Thyroiditis, Autoimmune; Ursodeoxycholic Acid; Young Adult

2019
Adherence to ursodeoxycholic acid therapy in patients with cholestatic and autoimmune liver disease.
    Clinics and research in hepatology and gastroenterology, 2019, Volume: 43, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Cholagogues and Choleretics; Cholestasis; Female; Humans; Liver Diseases; Male; Medication Adherence; Middle Aged; Prospective Studies; Ursodeoxycholic Acid; Young Adult

2019
Identification of a primary biliary cirrhosis associated protein as lysosome-associated membrane protein-2.
    Journal of proteomics, 2013, Oct-08, Volume: 91

    Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Cell Differentiation; Dogs; Gene Expression Regulation; Humans; Hybridomas; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Lysosomal-Associated Membrane Protein 2; Madin Darby Canine Kidney Cells; Molecular Sequence Data; Prognosis; Protein Binding; Recombinant Proteins; RNA, Messenger; Tissue Distribution; Ursodeoxycholic Acid

2013
[Hepatobiliary lesions in Crohn's disease and conservative methods of treatment].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2013, Issue:6

    Topics: Biliary Tract Diseases; Cholagogues and Choleretics; Crohn Disease; Drug Therapy, Combination; Humans; Liver Diseases; Treatment Outcome; Ursodeoxycholic Acid

2013
[Ursodeoxycholic acid-enhanced efficiency and safety of statin therapy in patients with liver, gallbladder, and/or biliary tract diseases: the RACURS study].
    Terapevticheskii arkhiv, 2014, Volume: 86, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Biliary Tract Diseases; Cardiovascular Diseases; Drug Synergism; Drug Therapy, Combination; Gallbladder Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Diseases; Middle Aged; Risk; Treatment Outcome; Ursodeoxycholic Acid

2014
Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.
    Journal of hepatology, 2015, Volume: 63, Issue:4

    Topics: Animals; Apoptosis; Bile Acids and Salts; Bile Ducts; Calcium; Cell Proliferation; Cells, Cultured; Cholagogues and Choleretics; Cysts; Disease Models, Animal; Liver; Liver Diseases; Rats; Tandem Mass Spectrometry; Ursodeoxycholic Acid

2015
Ursodeoxycholic Acid for Treatment of Enlarged Polycystic Liver.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2016, Volume: 20, Issue:1

    Topics: Aged; Alkaline Phosphatase; Cholagogues and Choleretics; Cysts; Drug Monitoring; Female; gamma-Glutamyltransferase; Humans; Liver; Liver Diseases; Male; Middle Aged; Organ Size; Polycystic Kidney Diseases; Renal Dialysis; Tomography, X-Ray Computed; Treatment Outcome; Ursodeoxycholic Acid

2016
Liver Sarcoidosis with Unique MRI Images Using Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid.
    Acta medica Okayama, 2015, Volume: 69, Issue:5

    Topics: Female; Gadolinium DTPA; Humans; Liver Diseases; Magnetic Resonance Imaging; Middle Aged; Sarcoidosis; Tomography, X-Ray Computed; Ursodeoxycholic Acid

2015
Supplementation of ursodeoxycholic acid improves fat digestion and absorption in cystic fibrosis patients with mild liver involvement.
    European journal of gastroenterology & hepatology, 2016, Volume: 28, Issue:6

    Topics: Adolescent; Adult; Breath Tests; Carbon Isotopes; Child; Child, Preschool; Cholagogues and Choleretics; Cystic Fibrosis; Dietary Fats; Dietary Supplements; Female; Humans; Liver Diseases; Male; Triglycerides; Ursodeoxycholic Acid; Young Adult

2016
The Association of Ursodeoxycholic Acid Use With Colorectal Cancer Risk: A Nationwide Cohort Study.
    Medicine, 2016, Volume: 95, Issue:11

    Topics: Adult; Aged; Chemoprevention; Cholagogues and Choleretics; Cohort Studies; Colorectal Neoplasms; Databases, Factual; Female; Humans; Incidence; Liver Diseases; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Taiwan; Ursodeoxycholic Acid

2016
Long-Term Ursodeoxycholic Acid Therapy Does Not Alter Lithocholic Acid Levels in Patients with Cystic Fibrosis with Associated Liver Disease.
    The Journal of pediatrics, 2016, Volume: 177

    Topics: Adolescent; Adult; Bile Acids and Salts; Biotransformation; Child; Child, Preschool; Cystic Fibrosis; Deoxycholic Acid; Female; Humans; Lithocholic Acid; Liver Diseases; Male; Tandem Mass Spectrometry; Ursodeoxycholic Acid; Young Adult

2016
Cystic Fibrosis Liver Disease and Ursodeoxycholic Acid: One Small Step Forward, Miles to Go.
    The Journal of pediatrics, 2016, Volume: 177

    Topics: Bile Acids and Salts; Cystic Fibrosis; Humans; Liver; Liver Diseases; Ursodeoxycholic Acid

2016
Hepatic sarcoidosis: a case series.
    The Pan African medical journal, 2016, Volume: 24

    Topics: Adult; Biopsy; Female; Glucocorticoids; Granuloma; Humans; Liver Diseases; Male; Middle Aged; Retrospective Studies; Sarcoidosis; Treatment Outcome; Ursodeoxycholic Acid

2016
Liver disease associated with ZZ alpha1-antitrypsin deficiency and ursodeoxycholic acid therapy in children.
    Journal of pediatric gastroenterology and nutrition, 2008, Volume: 47, Issue:5

    Topics: Alanine Transaminase; alpha 1-Antitrypsin Deficiency; Aspartate Aminotransferases; Bilirubin; Child; Child, Preschool; Female; Follow-Up Studies; gamma-Glutamyltransferase; Humans; Infant; Infant, Newborn; Liver Diseases; Liver Function Tests; Male; Phenotype; Recurrence; Retrospective Studies; Ursodeoxycholic Acid

2008
Ursodeoxycholic acid for treatment of cholestasis in patients with hepatic amyloidosis.
    Vojnosanitetski pregled, 2009, Volume: 66, Issue:6

    Topics: Adult; Aged; Amyloidosis; Cholagogues and Choleretics; Cholestasis; Female; Humans; Liver Diseases; Male; Middle Aged; Ursodeoxycholic Acid

2009
Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2010, Volume: 42, Issue:6

    Topics: Child; Child, Preschool; Cholagogues and Choleretics; Chronic Disease; Cystic Fibrosis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infant; Italy; Liver Diseases; Male; Morbidity; Retrospective Studies; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid

2010
Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
    Journal of pediatric surgery, 2010, Volume: 45, Issue:1

    Topics: Bilirubin; Biomarkers; Child; Child, Preschool; Cholestasis, Intrahepatic; Enteral Nutrition; Enterocolitis, Necrotizing; Fat Emulsions, Intravenous; Gastrointestinal Motility; Humans; Infant; Infant, Newborn; Infant, Premature; Intestinal Diseases; Intestinal Obstruction; Intestine, Small; Intestines; Liver Diseases; Organ Transplantation; Parenteral Nutrition; Patient Care Team; Postoperative Complications; Referral and Consultation; Rehabilitation Centers; Short Bowel Syndrome; Treatment Outcome; Ursodeoxycholic Acid

2010
[Usefulness of ursodeoxycholic acid in a case of hepatic sarciodosis].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2010, Volume: 107, Issue:4

    Topics: Adult; Cholagogues and Choleretics; Humans; Liver Diseases; Male; Sarcoidosis; Ursodeoxycholic Acid

2010
Titration of bile acid supplements in 3beta-hydroxy-Delta 5-C27-steroid dehydrogenase/isomerase deficiency.
    Journal of pediatric gastroenterology and nutrition, 2010, Volume: 50, Issue:6

    Topics: 3-Hydroxysteroid Dehydrogenases; Biopsy; Chenodeoxycholic Acid; Child; Child, Preschool; Cholagogues and Choleretics; Cholic Acids; Chromatography, Liquid; Dietary Supplements; Disease Progression; Humans; Infant; Infant, Newborn; Isomerases; Liver Diseases; Steroid Metabolism, Inborn Errors; Tandem Mass Spectrometry; Treatment Outcome; Ursodeoxycholic Acid

2010
Antibiotic treatment is superior to ursodeoxycholic acid on total parenteral nutrition associated hepatic dysfunction.
    Pediatric surgery international, 2010, Volume: 26, Issue:5

    Topics: Analysis of Variance; Animals; Apoptosis; bcl-2-Associated X Protein; Bilirubin; Caspase 3; Fas Ligand Protein; Gentamicins; Immunoenzyme Techniques; In Situ Nick-End Labeling; Liver Diseases; Malondialdehyde; Metronidazole; Oxidative Stress; Parenteral Nutrition, Total; Peroxidase; Rabbits; Ursodeoxycholic Acid

2010
[Bile acids in norm and pathology].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2010, Issue:4

    Topics: Bile; Bile Acids and Salts; Biological Transport; Cholagogues and Choleretics; Humans; Lipid Metabolism; Liver Diseases; Molecular Structure; Ursodeoxycholic Acid

2010
Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
    Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:5

    Topics: Animals; Apoptosis; Bile; Bile Acids and Salts; Carcinoma, Hepatocellular; Cholangitis; Cholestasis; Chromatography, Gas; Hepatoblastoma; Humans; Liver; Liver Diseases; Liver Neoplasms; Male; Mice; Rats; Rats, Sprague-Dawley; Taurine; Taurolithocholic Acid; Ursodeoxycholic Acid

2010
[Intrahepatic cholestasis in chronic liver diseases].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2011, Issue:2

    Topics: Blood Coagulation; Cholestasis, Intrahepatic; Chronic Disease; Drug Therapy, Combination; Humans; Liver Diseases; Liver Function Tests; Prognosis; Quality of Life; S-Adenosylmethionine; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid

2011
Therapeutic approaches for hepatobiliary disorders with ursodeoxycholic acid and bile-acid derivatives.
    Clinics and research in hepatology and gastroenterology, 2012, Volume: 36 Suppl 1

    Topics: Bile Acids and Salts; Biliary Tract Diseases; Cholagogues and Choleretics; Cholangitis, Sclerosing; Gastrointestinal Agents; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Treatment Outcome; Ursodeoxycholic Acid

2012
Prevention and treatment of intestinal failure-associated liver disease in children.
    Seminars in liver disease, 2012, Volume: 32, Issue:4

    Topics: Cholagogues and Choleretics; Cholestasis; Fat Emulsions, Intravenous; Fatty Liver; Humans; Intestinal Diseases; Liver Cirrhosis; Liver Diseases; Parenteral Nutrition; Ursodeoxycholic Acid

2012
Ursodiol does not prevent hepatic venoocclusive disease associated with Mylotarg therapy.
    Haematologica, 2002, Volume: 87, Issue:10

    Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Bilirubin; Cholagogues and Choleretics; Cohort Studies; Drug Interactions; Female; Gemtuzumab; Hepatic Veno-Occlusive Disease; Humans; Immunotoxins; Liver Diseases; Male; Middle Aged; Myelodysplastic Syndromes; Sialic Acid Binding Ig-like Lectin 3; Stem Cell Transplantation; Time Factors; Ursodeoxycholic Acid

2002
Diagnosis and management of hepatic copper accumulation in a Skye terrier.
    The Journal of small animal practice, 2003, Volume: 44, Issue:2

    Topics: Animals; Ascites; Colchicine; Copper; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Liver; Liver Diseases; Radiography; Seizures; Ultrasonography; Ursodeoxycholic Acid; Vomiting; Zinc

2003
Ursodeoxycholic acid treatment of idiopathic thrombocytopenic purpura with liver dysfunction.
    European journal of haematology, 2003, Volume: 71, Issue:5

    Topics: Adult; Fatty Liver; Female; Humans; Liver Diseases; Male; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Ursodeoxycholic Acid

2003
Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis.
    Hepatology (Baltimore, Md.), 2004, Volume: 39, Issue:6

    Topics: Adolescent; Bile Acids and Salts; Child; Child, Preschool; Cholic Acid; Cystic Fibrosis; Female; Humans; Infant; Liver Diseases; Male; Predictive Value of Tests; Prognosis; Ursodeoxycholic Acid

2004
[Treatment of autoimmune hepatic diseases].
    Klinicheskaia meditsina, 2004, Volume: 82, Issue:10

    Topics: Adult; Autoimmune Diseases; Child; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis, Intrahepatic; Drug Therapy, Combination; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Diseases; Prognosis; Risk Factors; Syndrome; Time Factors; Ursodeoxycholic Acid

2004
Demonstration of reversed flow in segmental branches of the portal vein with hand-held color Doppler ultrasonography after hematopoietic stem cell transplantation.
    Bone marrow transplantation, 2005, Volume: 36, Issue:12

    Topics: Adolescent; Adult; Aged; Child; Disease Progression; Female; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Hypertension, Portal; Liver Diseases; Male; Middle Aged; Portal Vein; Time Factors; Treatment Outcome; Ultrasonography; Ultrasonography, Doppler; Ursodeoxycholic Acid

2005
Ursodeoxycholic acid treatment in isolated chronic graft-vs.-host disease of the liver.
    Clinical transplantation, 2005, Volume: 19, Issue:6

    Topics: Adolescent; Adult; Aspartate Aminotransferases; Bilirubin; Cholagogues and Choleretics; Female; gamma-Glutamyltransferase; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Liver Diseases; Male; Middle Aged; Prospective Studies; Transplantation Conditioning; Ursodeoxycholic Acid

2005
[Non-hepatic manifestations of the overlap syndrome (a case report)].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2006, Issue:6

    Topics: Anti-Inflammatory Agents; Budesonide; Cholagogues and Choleretics; Diagnosis, Differential; Drug Therapy, Combination; Dry Eye Syndromes; Female; Humans; Liver Diseases; Middle Aged; Syndrome; Ursodeoxycholic Acid; Xerostomia

2006
Protective effects of ursodeoxycholic acid on chenodeoxycholic acid-induced liver injury in hamsters.
    World journal of gastroenterology, 2007, Oct-07, Volume: 13, Issue:37

    Topics: Alanine Transaminase; Animals; Bile Acids and Salts; Body Weight; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cricetinae; Eating; Liver; Liver Diseases; Mesocricetus; Ursodeoxycholic Acid

2007
Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production.
    European journal of pharmacology, 2008, Jan-06, Volume: 578, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Chemokine CXCL2; Cholagogues and Choleretics; Concanavalin A; Dose-Response Relationship, Drug; Gene Expression Regulation; Interferon-gamma; Interleukins; Liver; Liver Diseases; Male; Mice; Mice, Inbred BALB C; Neutrophil Infiltration; RNA, Messenger; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid

2008
Anabolic-androgenic steroids and liver injury.
    Liver international : official journal of the International Association for the Study of the Liver, 2008, Volume: 28, Issue:2

    Topics: Adult; Anabolic Agents; Androgens; Chemical and Drug Induced Liver Injury; Cholestasis; Hepatomegaly; Humans; Liver Diseases; Male; Treatment Outcome; Ursodeoxycholic Acid

2008
Role of ursodeoxycholic acid in prevention of methotrexate-induced liver toxicity.
    Digestive diseases and sciences, 2008, Volume: 53, Issue:4

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cholagogues and Choleretics; Immunosuppressive Agents; Lipid Peroxidation; Liver Diseases; Male; Methotrexate; Oxidative Stress; Rats; Rats, Wistar; Ursodeoxycholic Acid

2008
A single centre experience of liver disease in adults with cystic fibrosis 1995-2006.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2008, Volume: 7, Issue:3

    Topics: Adult; Cholagogues and Choleretics; Comorbidity; Cystic Fibrosis; Female; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Male; Platelet Count; Prospective Studies; Splenomegaly; Thrombocytopenia; Ursodeoxycholic Acid

2008
[Extrasecretory liver function disorder in patients with chronic pancreatitis].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2007, Issue:6

    Topics: Abdominal Pain; Adult; Bile; Cholagogues and Choleretics; Female; Gallbladder; Humans; Liver; Liver Diseases; Male; Middle Aged; Pancreatitis, Chronic; Sphincter of Oddi; Ursodeoxycholic Acid

2007
[Jeune'disease (asphyxiating thoracic dystrophy) and respiratory failure: importance of early respiratory management with periodic hyperinsufflation].
    Bulletin de l'Academie nationale de medecine, 2007, Volume: 191, Issue:7

    Topics: Child; Child, Preschool; Disease Management; Female; Fetal Diseases; Genes, Recessive; Humans; Infant; Infant, Newborn; Insufflation; Liver Diseases; Male; Osteochondrodysplasias; Prenatal Diagnosis; Respiration, Artificial; Respiratory Insufficiency; Ribs; Tracheostomy; Treatment Outcome; Ursodeoxycholic Acid

2007
Portal-systemic spill-over of bile acids: a study of mechanisms using ursodeoxycholic acid.
    European journal of clinical investigation, 1983, Volume: 13, Issue:6

    Topics: Adult; Bile Acids and Salts; Chronic Disease; Deoxycholic Acid; Female; Humans; Kinetics; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Ursodeoxycholic Acid

1983
[Significance and limitations of oral UDCA loading in liver function test].
    Nihon rinsho. Japanese journal of clinical medicine, 1984, Volume: 42, Issue:7

    Topics: Bile Acids and Salts; Biological Availability; Deoxycholic Acid; Diagnosis, Differential; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Ursodeoxycholic Acid

1984
[Hepatology in 1981].
    La Revue du praticien, 1981, Dec-21, Volume: 31, Issue:59

    Topics: Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cholelithiasis; Chronic Disease; Hepatitis; Humans; Liver Cirrhosis, Alcoholic; Liver Diseases; Liver Transplantation; Peliosis Hepatis; Peritoneovenous Shunt; Ursodeoxycholic Acid

1981
Direct measurement of hepatic extraction of chenodeoxycholic acid and ursodeoxycholic acid in man.
    Clinical science (London, England : 1979), 1982, Volume: 63, Issue:2

    Topics: Adult; Aged; Chenodeoxycholic Acid; Female; Humans; Liver; Liver Diseases; Male; Middle Aged; Ursodeoxycholic Acid

1982
[Change of serum bile acids levels after administration of UDCA and test meals (author's transl)].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1982, Volume: 79, Issue:2

    Topics: Bile Acids and Salts; Deoxycholic Acid; Humans; Liver Diseases; Ursodeoxycholic Acid

1982
Hepatotoxicity of bile acids in rabbits: ursodeoxycholic acid is less toxic than chenodeoxycholic acid.
    Laboratory investigation; a journal of technical methods and pathology, 1982, Volume: 46, Issue:4

    Topics: Animals; Bile Canaliculi; Body Weight; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cytoskeleton; Deoxycholic Acid; Lithocholic Acid; Liver; Liver Diseases; Prognosis; Rabbits; Ursodeoxycholic Acid

1982
[A clinical significance of oral ursodeoxycholic acid tolerance test for patients with hepatobiliary diseases by using radioimmunoassay (author's transl)].
    Rinsho byori. The Japanese journal of clinical pathology, 1981, Volume: 29, Issue:5

    Topics: Biliary Tract Diseases; Deoxycholic Acid; Drug Tolerance; Humans; Liver Diseases; Radioimmunoassay; Ursodeoxycholic Acid

1981
[A comparative study of serum bile acid levels (TBA, CG) in liver disease-difference between fasting and UDCA oral loading (author's transl)].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1981, Volume: 78, Issue:11

    Topics: Administration, Oral; Bile Acids and Salts; Deoxycholic Acid; Fasting; Humans; Liver Diseases; Ursodeoxycholic Acid

1981
Hepatotoxic effect of bile acids in inflammatory bowel disease.
    Gastroenterology, 1980, Volume: 78, Issue:6

    Topics: Adult; Aged; Bile Acids and Salts; Biotransformation; Colitis, Ulcerative; Crohn Disease; Female; Humans; Lithocholic Acid; Liver; Liver Diseases; Male; Middle Aged; Stereoisomerism; Sulfates; Ursodeoxycholic Acid

1980
[Treatment of cholestatic liver diseases with phenobarbital and ursodeoxycholic acid].
    Zeitschrift fur Gastroenterologie, 1993, Volume: 31 Suppl 2

    Topics: Cholestasis, Intrahepatic; Cystic Fibrosis; Female; Humans; Liver Diseases; Liver Function Tests; Male; Phenobarbital; Pregnancy; Pregnancy Complications; Treatment Outcome; Ursodeoxycholic Acid

1993
Regulation of bile acid synthesis by deoxycholic acid in the rat: different effects on cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase.
    Hepatology (Baltimore, Md.), 1995, Volume: 22, Issue:4 Pt 1

    Topics: Animals; Bile; Bile Acids and Salts; Cell Nucleus; Chemical and Drug Induced Liver Injury; Cholagogues and Choleretics; Cholestanetriol 26-Monooxygenase; Cholesterol 7-alpha-Hydroxylase; Cytochrome P-450 Enzyme System; Deoxycholic Acid; Diet; Hydroxymethylglutaryl CoA Reductases; Liver; Liver Diseases; Male; Necrosis; Rats; Rats, Sprague-Dawley; RNA, Messenger; Steroid Hydroxylases; Ursodeoxycholic Acid

1995
Metabolism, pharmacokinetics, and activity of a new 6-fluoro analogue of ursodeoxycholic acid in rats and hamsters.
    Gastroenterology, 1995, Volume: 108, Issue:4

    Topics: Albumins; Animals; Bile; Chemical and Drug Induced Liver Injury; Cricetinae; Hydrogen-Ion Concentration; Liver Diseases; Male; Mesocricetus; Protein Binding; Rats; Rats, Sprague-Dawley; Solubility; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid

1995
[The influence of bear acid on lipid metabolism. A future drug?].
    Lakartidningen, 1995, Apr-05, Volume: 92, Issue:14

    Topics: Animals; Cholelithiasis; Humans; Lipid Metabolism; Liver; Liver Diseases; Ursidae; Ursodeoxycholic Acid

1995
[Measurement of bile acid N-acetylglucosaminides in serum and urine of patients with chronic liver diseases during ursodeoxycholic acid treatment].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1995, Volume: 92, Issue:3

    Topics: Acetylglucosamine; Bile Acids and Salts; Chronic Disease; Humans; Liver Diseases; Middle Aged; Ursodeoxycholic Acid

1995
Treatment with Ursodeoxycholic Acid in Clinical Hepatology. Proceedings of a workshop. Goteborg, Sweden, 3-4 February 1994.
    Scandinavian journal of gastroenterology. Supplement, 1994, Volume: 204

    Topics: Animals; Humans; Liver; Liver Diseases; Ursodeoxycholic Acid

1994
Clinicopathological study of proliferating cell nuclear antigen (PCNA) of hepatocytes in primary biliary cirrhosis.
    Journal of gastroenterology, 1994, Volume: 29, Issue:1

    Topics: Chronic Disease; DNA; Female; Humans; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Ursodeoxycholic Acid

1994
Effect of ursodeoxycholic acid on in vivo and in vitro toxic liver injury in rats.
    Alimentary pharmacology & therapeutics, 1994, Volume: 8, Issue:3

    Topics: Acetaminophen; Administration, Oral; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Ethanol; Lipid Peroxides; Liver; Liver Diseases; Male; Rats; Ursodeoxycholic Acid; Valine

1994
[Clinical significance of 3 beta, 7 beta-dihydroxy-5 beta-cholan-24-oic acid (isoUDCA) in serum during administration of ursodeoxycholic acid].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1993, Volume: 90, Issue:11

    Topics: Chenodeoxycholic Acid; Humans; Liver Diseases; Ursodeoxycholic Acid

1993
Effects of selective zonal injury on bile acid-induced bile flow in the isolated rat liver.
    The American journal of physiology, 1993, Volume: 264, Issue:6 Pt 1

    Topics: Animals; Bile; Bile Acids and Salts; Biotransformation; Chenodeoxycholic Acid; Cholagogues and Choleretics; In Vitro Techniques; Liver; Liver Diseases; Male; Rats; Rats, Wistar; Taurocholic Acid; Ursodeoxycholic Acid

1993
Early hepatobiliary dysfunction during total parenteral nutrition: an experimental study.
    Journal of pediatric surgery, 1993, Volume: 28, Issue:1

    Topics: Animals; Bile Acids and Salts; Bile Duct Diseases; Cholesterol; Female; Liver Diseases; Parenteral Nutrition, Total; Rabbits; Sulfobromophthalein; Time Factors; Ursodeoxycholic Acid

1993
The role of hepatobiliary scintigraphy in cystic fibrosis.
    Hepatology (Baltimore, Md.), 1996, Volume: 23, Issue:2

    Topics: Adolescent; Adult; Biliary Tract; Child; Child, Preschool; Cystic Fibrosis; Female; Follow-Up Studies; Humans; Infant; Liver; Liver Diseases; Male; Prospective Studies; Radionuclide Imaging; Taurine; Ultrasonography; Ursodeoxycholic Acid

1996
Should we treat cholestatic liver disease with cholesterol synthesis inhibitors?
    The American journal of gastroenterology, 1996, Volume: 91, Issue:2

    Topics: Anticholesteremic Agents; Cholagogues and Choleretics; Cholestasis; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid

1996
Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis.
    Digestive diseases and sciences, 1996, Volume: 41, Issue:7

    Topics: Adult; Aged; Cells, Cultured; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Chronic Disease; Deoxycholic Acid; Dinoprostone; Female; Hepatitis C; Humans; Indomethacin; Killer Cells, Natural; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Ursodeoxycholic Acid

1996
Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene.
    Gastroenterology, 1996, Volume: 111, Issue:1

    Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Bile; Chemical and Drug Induced Liver Injury; Cholangitis; Cholic Acids; Drug Resistance, Multiple; Food, Formulated; Gene Expression; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Mice; Mice, Mutant Strains; Ursodeoxycholic Acid

1996
Increase of sulfated ursodeoxycholic acid in the serum and urine of patients with chronic liver disease after ursodeoxycholic acid therapy.
    Journal of gastroenterology and hepatology, 1996, Volume: 11, Issue:4

    Topics: Adult; Aged; Bile Acids and Salts; Chronic Disease; Female; Humans; Liver; Liver Diseases; Liver Function Tests; Male; Middle Aged; Sulfates; Ursodeoxycholic Acid

1996
Bile acid research and applications.
    Lancet (London, England), 1997, Jan-04, Volume: 349, Issue:9044

    Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Cholelithiasis; Cholestasis, Intrahepatic; Female; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Pregnancy; Pregnancy Complications; Research; Ursodeoxycholic Acid

1997
Hepatic GVHD after HLA-haploidentical bone marrow transplantation in children with severe combined immunodeficiency: the effect of ursodeoxycholic acid.
    British journal of haematology, 1997, Volume: 96, Issue:4

    Topics: Adrenal Cortex Hormones; Bile Duct Diseases; Bilirubin; Bone Marrow Transplantation; Cholagogues and Choleretics; Cyclosporine; Fibrosis; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Liver Diseases; Male; Severe Combined Immunodeficiency; Skin Diseases; Ursodeoxycholic Acid

1997
Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis.
    Digestive diseases and sciences, 1997, Volume: 42, Issue:4

    Topics: Cholagogues and Choleretics; Cholestasis, Intrahepatic; Chronic Disease; Female; Humans; Liver; Liver Diseases; Middle Aged; Sarcoidosis; Ursodeoxycholic Acid

1997
The role of bile salt composition in liver pathology of mdr2 (-/-) mice: differences between males and females.
    Journal of hepatology, 1997, Volume: 26, Issue:1

    Topics: Animals; Bile Acids and Salts; Diet; Female; Genes, MDR; Liver Diseases; Male; Mice; Mice, Knockout; Sex Characteristics; Solubility; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid; Water

1997
Hepatic complications of erythropoietic protoporphyria.
    Photodermatology, photoimmunology & photomedicine, 1998, Volume: 14, Issue:2

    Topics: Adolescent; Adult; Cholestasis, Intrahepatic; Coproporphyrins; Female; Humans; Liver Diseases; Liver Transplantation; Male; Middle Aged; Porphyria, Hepatoerythropoietic; Protoporphyrins; Ursodeoxycholic Acid

1998
Assessment of biliary bicarbonate secretion in humans by positron emission tomography.
    Gastroenterology, 1999, Volume: 117, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Bicarbonates; Bile Ducts; Biliary Tract Diseases; Cholestasis, Extrahepatic; Female; Gastrointestinal Agents; Humans; Injections, Intravenous; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Reference Values; Secretin; Sodium Bicarbonate; Tomography, Emission-Computed; Ursodeoxycholic Acid

1999
Delayed intestinal visualization at hepatobiliary scintigraphy is associated with response to long-term treatment with ursodeoxycholic acid in patients with cystic fibrosis-associated liver disease.
    Journal of hepatology, 1999, Volume: 31, Issue:4

    Topics: Adolescent; Adult; Bile Ducts; Child; Child, Preschool; Cholagogues and Choleretics; Cystic Fibrosis; Female; Humans; Intestines; Liver; Liver Diseases; Male; Radionuclide Imaging; Time Factors; Treatment Failure; Ultrasonography; Ursodeoxycholic Acid

1999
Jeune syndrome and liver disease: report of three cases treated with ursodeoxycholic acid.
    American journal of medical genetics, 1999, Dec-03, Volume: 87, Issue:4

    Topics: Alanine Transaminase; Aspartate Aminotransferases; Asphyxia Neonatorum; Child; Child, Preschool; Cholagogues and Choleretics; Female; Follow-Up Studies; gamma-Glutamyltransferase; Humans; Infant; Infant, Newborn; Liver Diseases; Male; Osteochondrodysplasias; Treatment Outcome; Ursodeoxycholic Acid

1999
Autoimmune cholangitis within the spectrum of autoimmune liver disease.
    Hepatology (Baltimore, Md.), 2000, Volume: 31, Issue:6

    Topics: Adrenal Cortex Hormones; Adult; Autoimmune Diseases; Cholagogues and Choleretics; Cholangitis; Female; HLA Antigens; Humans; Liver Diseases; Male; Middle Aged; Prospective Studies; Ursodeoxycholic Acid

2000
The chronic disease of childhood obesity: the sleeping giant has awakened.
    The Journal of pediatrics, 2000, Volume: 136, Issue:6

    Topics: Alanine Transaminase; Aspartate Aminotransferases; Child; Chronic Disease; Fatty Liver; Health Promotion; Humans; Life Style; Liver Diseases; Obesity; Ursodeoxycholic Acid

2000
Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease.
    Journal of clinical gastroenterology, 2001, Volume: 32, Issue:4

    Topics: Adolescent; Adult; Child; Child, Preschool; Cholagogues and Choleretics; Cystic Fibrosis; Female; Humans; Liver Diseases; Liver Function Tests; Longitudinal Studies; Male; Prospective Studies; Treatment Outcome; Ultrasonography; Ursodeoxycholic Acid

2001
Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2000, Volume: 32, Issue:4

    Topics: Alkaline Phosphatase; Animals; Bile Acids and Salts; Carrier Proteins; Chenodeoxycholic Acid; Humans; Hydroxysteroid Dehydrogenases; L-Lactate Dehydrogenase; Liver; Liver Diseases; Male; Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid

2000
[Ursodeoxycholic acid as the main treatment of hepatobiliary diseases in children and teenagers].
    Rossiiskii gastroenterologicheskii zhurnal : ezhekvartalnyi nauchno-prakticheskii zhurnal, 2001, Issue:1

    Topics: Adolescent; Bile Duct Diseases; Child; Humans; Liver Diseases; Ursodeoxycholic Acid

2001
Hepatic hydroxylation of bile acids and chronic liver diseases: do transporters play a mechanistic role?
    Journal of gastroenterology and hepatology, 2001, Volume: 16, Issue:12

    Topics: Bile Acids and Salts; Biliary Tract Diseases; Carrier Proteins; Chronic Disease; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple; Humans; Hydroxylation; Liver; Liver Diseases; Membrane Transport Proteins; Organic Anion Transporters, Sodium-Dependent; Symporters; Ursodeoxycholic Acid

2001
Clinical utility of ursodeoxycholic acid in preventing flutamide-induced hepatopathy in patients with prostate cancer: a preliminary study.
    International journal of urology : official journal of the Japanese Urological Association, 2002, Volume: 9, Issue:1

    Topics: Aged; Antineoplastic Agents, Hormonal; Chemical and Drug Induced Liver Injury; Flutamide; Humans; Liver Diseases; Male; Prostatic Neoplasms; Retrospective Studies; Ursodeoxycholic Acid

2002
[Ursotherapy in hepatobiliary diseases].
    Acta gastroenterologica Latinoamericana, 1992, Volume: 22, Issue:3

    Topics: Chenodeoxycholic Acid; Cholelithiasis; Cholestasis; Humans; Liver Diseases; Ursodeoxycholic Acid

1992
Chronic graft-vs.-host disease of the liver: another indication of ursodeoxycholic acid?
    Hepatology (Baltimore, Md.), 1992, Volume: 16, Issue:5

    Topics: Bone Marrow Transplantation; Graft vs Host Disease; Humans; Liver Diseases; Ursodeoxycholic Acid

1992
[Factors influencing the effect of ursodeoxycholic acid therapy in chronic hypertransaminasemia].
    Recenti progressi in medicina, 1992, Volume: 83, Issue:5

    Topics: Adult; Aged; Chronic Disease; Clinical Enzyme Tests; Female; Hepatitis; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Male; Middle Aged; Regression Analysis; Transaminases; Ursodeoxycholic Acid

1992
Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease.
    Hepatology (Baltimore, Md.), 1992, Volume: 15, Issue:4

    Topics: Adolescent; Bile Ducts; Child; Cystic Fibrosis; Female; Humans; Liver; Liver Diseases; Male; Radionuclide Imaging; Ursodeoxycholic Acid

1992
Lithocholic acid accumulation.
    Hospital practice (Office ed.), 1992, Jun-15, Volume: 27, Issue:6

    Topics: Animals; Chronic Disease; Humans; Lithocholic Acid; Liver; Liver Diseases; Ursodeoxycholic Acid

1992
Liver and biliary problems in cystic fibrosis.
    Journal of the Royal Society of Medicine, 1992, Volume: 85 Suppl 19

    Topics: Adolescent; Adult; Age Factors; Animals; Biliary Tract Diseases; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Infant; Infant, Newborn; Liver Diseases; Liver Transplantation; Male; Rats; Ursodeoxycholic Acid

1992
Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7 beta-hydroxylated bile acids in humans.
    The Journal of clinical investigation, 1992, Volume: 89, Issue:6

    Topics: Acetylglucosamine; Administration, Oral; Bile Acids and Salts; Chenodeoxycholic Acid; Cholestasis; Deoxycholic Acid; Glycosides; Humans; Hydroxylation; Liver Diseases; Mass Spectrometry; Ursodeoxycholic Acid

1992
Effect of ursodeoxycholic acid on experimental hepatic porphyria induced by griseofulvin.
    Journal of Korean medical science, 1991, Volume: 6, Issue:2

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Bilirubin; Chemical and Drug Induced Liver Injury; Griseofulvin; Liver Diseases; Mice; Mice, Inbred ICR; Microscopy, Electron; Porphobilinogen; Porphyrias; Ursodeoxycholic Acid

1991
Formation of iso-ursodeoxycholic acid during administration of ursodeoxycholic acid in man.
    Journal of hepatology, 1991, Volume: 13, Issue:1

    Topics: Adult; Aminopyrine; Bile; Bile Acids and Salts; Carbon Isotopes; Carbon Radioisotopes; Cholestasis; Female; Humans; Intestines; Liver Diseases; Male; Microsomes, Liver; Middle Aged; Ursodeoxycholic Acid

1991
[The influence of ursodesoxycholic acid (URSO) on griseofulvin (GF)-induced protoporphyria].
    Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology, 1991, Volume: 101, Issue:8

    Topics: Animals; Chemical and Drug Induced Liver Injury; Griseofulvin; Liver Diseases; Male; Mice; Mice, Inbred Strains; Porphyrias; Protoporphyrins; Ursodeoxycholic Acid

1991
Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat.
    Gastroenterology, 1991, Volume: 100, Issue:1

    Topics: Animals; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Cholestasis; Liver Diseases; Male; Necrosis; Rats; Rats, Inbred Strains; Ursodeoxycholic Acid

1991
Importance of bile acid structure in amelioration of griseofulvin-induced murine protoporphyric hepatopathy.
    The Journal of laboratory and clinical medicine, 1991, Volume: 118, Issue:1

    Topics: Absorption; Animals; Bile; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cholestasis, Intrahepatic; Cholic Acid; Cholic Acids; Female; Griseofulvin; Liver; Liver Diseases; Mice; Protoporphyrins; Structure-Activity Relationship; Ursodeoxycholic Acid

1991
Formation of biliary thrombi in protoporphyrin-induced cholestasis in perfused rat liver.
    Hepatology (Baltimore, Md.), 1990, Volume: 11, Issue:5

    Topics: Animals; Bile; Bile Acids and Salts; Biliary Tract Diseases; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cholestasis; In Vitro Techniques; L-Lactate Dehydrogenase; Liver; Liver Diseases; Microscopy, Electron; Perfusion; Porphyrins; Protoporphyrins; Rats; Rats, Inbred Strains; Taurocholic Acid; Ursodeoxycholic Acid

1990
Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration.
    Hepatology (Baltimore, Md.), 1990, Volume: 12, Issue:2

    Topics: Adolescent; Bile Acids and Salts; Child; Chromatography, High Pressure Liquid; Cystic Fibrosis; Deoxycholic Acid; Female; Gas Chromatography-Mass Spectrometry; Humans; Liver Diseases; Male; Mass Spectrometry; Ursodeoxycholic Acid

1990
Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis.
    The Journal of pediatrics, 1990, Volume: 117, Issue:3

    Topics: Adolescent; Bile Acids and Salts; Child; Cystic Fibrosis; Deoxycholic Acid; Female; Humans; Liver Diseases; Liver Function Tests; Male; Taurine; Ursodeoxycholic Acid

1990
[Erythrohepatic protoporphyria with rapidly progressing liver cirrhosis].
    Deutsche medizinische Wochenschrift (1946), 1989, Nov-24, Volume: 114, Issue:47

    Topics: Cholestyramine Resin; Humans; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Male; Middle Aged; Multiple Organ Failure; Porphyrias; Porphyrins; Protoporphyrins; Sepsis; Ursodeoxycholic Acid

1989
[The influence of ursodeoxycholic acid on hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan in chronic liver diseases].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1988, Volume: 85, Issue:11

    Topics: Adult; Biliary Tract; Chronic Disease; Deoxycholic Acid; Female; Humans; Liver; Liver Diseases; Male; Middle Aged; Organometallic Compounds; Organotechnetium Compounds; Pyridoxal; Radionuclide Imaging; Tryptophan; Ursodeoxycholic Acid

1988
[Clinical evaluation of ursodeoxycholic acid. Glucagon tolerance test in patients with chronic liver disease].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1988, Volume: 85, Issue:12

    Topics: Bile Acids and Salts; Chronic Disease; Deoxycholic Acid; Glucagon; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Predictive Value of Tests; Ursodeoxycholic Acid

1988
Differing effects of nor-ursodeoxycholic or ursodeoxycholic acid on hepatic histology and bile acid metabolism in the rabbit.
    Gastroenterology, 1986, Volume: 91, Issue:1

    Topics: Animals; Bile Acids and Salts; Deoxycholic Acid; Liver; Liver Diseases; Rabbits; Ursodeoxycholic Acid

1986
[The oral ursodeoxycholic acid test and its value in the diagnosis of liver diseases].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1986, Apr-28, Volume: 41, Issue:17

    Topics: Adolescent; Adult; Aged; Bile Acids and Salts; Deoxycholic Acid; Diagnosis, Differential; Evaluation Studies as Topic; Female; Humans; Liver Diseases; Liver Function Tests; Male; Middle Aged; Ursodeoxycholic Acid

1986
[Bile acids in chronic hepatopathies].
    Minerva medica, 1986, Dec-22, Volume: 77, Issue:49-50

    Topics: Adult; Bile Acids and Salts; Cholestasis; Chronic Disease; Diagnosis, Differential; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Middle Aged; Ursodeoxycholic Acid

1986